WO2023249915A1 - Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds - Google Patents

Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds Download PDF

Info

Publication number
WO2023249915A1
WO2023249915A1 PCT/US2023/025681 US2023025681W WO2023249915A1 WO 2023249915 A1 WO2023249915 A1 WO 2023249915A1 US 2023025681 W US2023025681 W US 2023025681W WO 2023249915 A1 WO2023249915 A1 WO 2023249915A1
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl group
branched
formula
linear
chosen
Prior art date
Application number
PCT/US2023/025681
Other languages
French (fr)
Inventor
Nicholas David STEBBINS
David Chan
Susan Halpern
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/844,930 external-priority patent/US20230404883A1/en
Priority claimed from US17/844,949 external-priority patent/US20230404882A1/en
Priority claimed from FR2211483A external-priority patent/FR3141622A1/en
Priority claimed from FR2211482A external-priority patent/FR3141624A1/en
Application filed by L'oreal filed Critical L'oreal
Publication of WO2023249915A1 publication Critical patent/WO2023249915A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/604Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present disclosure relates to cosmetic compositions comprising a combination of natural emulsifiers and compound of thiopyridlnone type.
  • ridn care active Ingredients it is preferable for ridn care active Ingredients to be absorbed by the ridn or penetrated into the skin as much as possible.
  • ridn absorption or ridn penetration of such ridn care active Ingredients Is not easy due to the barrier function of the skin.
  • one possible approach to enhance the ridn penetration of a skin care active ingredient may be to use a skin penetration enhancer with the skin care active ingredient.
  • the present disclosure relates to stable oil-in-water cosmetic compositions comprising compound of thiopyridinone type and a blend of natural emulsifiers.
  • the cosmetic compositions have low viscosity.
  • the compositions described in the instant disclosure are unique in comparison to other traditional oil-in-water compositions that contain emulsifiers containing PEG groups that offer the greatest flexibility and stability when formulating because of the oligomeric nature of the molecules.
  • emulsifiers containing PEG groups that offer the greatest flexibility and stability when formulating because of the oligomeric nature of the molecules.
  • natural-based emulsifiers are in far fewer number.
  • they do not have the same advantages as the aforementioned oligomeric emulsifiers.
  • Natural emulsifiers are often more difficult to formulate with, but they have benefits of naturality.
  • the inventors have discovered that the inclusion of a combination of compound of thiopyridinone type (I) or (I') and a blend of natural emulsifiers surprisingly stabilize oil-in-water cosmetic compositions and in some cases would enhance the penetration of the compound of thioprydinone type.
  • the oil-in-water cosmetic composition typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture:
  • R 1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
  • the oil-in-water cosmetic composition is physically stable.
  • the oil-in-water composition might comprise one or more Polyglyceryl Fatty Acid Ester.
  • the oil-in-water might comprise one or more oils.
  • the compound i) is typically present in the cosmetic compositions in an amount of from about 0.01 to about 10 wt.%, based on the total weight of the cosmetic composition. In some cases, the amount of compound I) is present in an amount of from about 0.1 to about 5 wt.%, based on the total weight of the cosmetic composition. In some embodiments, the compound i) is typically present in the cosmetic compositions in an amount of from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
  • the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have intermediate to high HLB. In some embodiments, the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have a HLB from about 10 to about 15. In one or more embodiments, the at least two or more natural emulsifiers has a HLB from about 10 to about 15.
  • the cosmetic composition may include at least two or more natural emulsifiers selected from the group consisting of inulin lauryl carbamate, C 1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
  • the at least two or more natural emulsifiers is inuline carbamate.
  • the cosmetic composition may include one or more Polyglyceryl Fatty Acid Ester.
  • the one or more Polyglyceryl Fatty Acid Ester have an HLB from about 8 to about 20.
  • the polyglyceryl fatty acid esters has a polyglyceryl moiety derived from 2 to 10 glycerins, preferably 2 to 8 glycerins, and more preferably from 2 to 6 glycerins.
  • the one or more polyglyceryl fatty acid ester Is chosen from polyglyceryl monolaurate comprising 2 to 6 glycerol units, polyglyceryl monocaprate comprising 2 to 6 glycerol units, polyglyceryl monooleate comprising 2 to 6 glycerol units, and polyglyceryl distearate comprising 2 to 6 glycerol units.
  • the one or more polyglyceryl fatty acid esters is selected from the group consisting of polyglyceryl-4 caprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dioleate, polyglyceryl-6 distearate, and mixtures thereof.
  • the one or more polyglyceryl fatty acid esters is present from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
  • the composition provides enhanced penetration of the i) compound of thiopyridinone type in an in vitro penetration test.
  • the at least two or more natural emulsifiers are present from about 0.3 to about 6 wt.%, based on the total weight of the cosmetic composition.
  • the sucrose have an intermediate to high HLB.
  • the i) compound of thiopyridinone type has a logP value ranging from about -1.5 to about 1.5.
  • the cosmetic composition might comprise one or more oils.
  • the cosmetic compositions may include non-natural emulsifiers.
  • the cosmetic compositions may include one or more thickening polymers.
  • the cosmetic compositions may include one or more fatty compounds.
  • the cosmetic composition has a low viscosity.
  • the cosmetic compositions may include inulin lauryl carbamate that can be present from about 0.2 wt.% to about 3 wt.%, based on the total weight of the cosmetic composition.
  • the cosmetic composition may have a pH ranging from about 4.5 to about 6.5, preferably from about 5 to about 6.
  • the cosmetic composition may include:
  • R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
  • R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; ii. about 0.5 to about 2 wt.% of at least two or more natural emulsifiers that are elected from the group consisting of inulin lauryl carbamate, C 12 -20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyi Alcohol (And) Behenyl Alcohol (And) Arachidyi Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof. wherein the weight percentages are
  • the cosmetic compositions may include: i) from about 0.01 to about 10 wt.% of at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
  • R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 1 0 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
  • R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1 -C12 or branched C3-C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals - R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1 -C10 or branched C3-C10 alkyl group;
  • the cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans.
  • the cosmetic composition provides enhanced penetration of the compound of thiopyridinone type into skin.
  • Another aspect of the instant disclosure is methods of increasing the percentage of the compound of thiopyridinone type deposited in skin, the method comprising topically applying the cosmetic composition of the instant disclosure to skin, wherein the cosmetic composition of the instant disclosure increases the percentage of the compound of thiopyridinone type deposited in the skin.
  • FIG. 1 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Base Formula and Comparative Examples.
  • FIG.2 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
  • FIG.3 is a graph showing the percentage of applied Niacinamide penetration for Base Formula and Comparative Examples.
  • FIG.4 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
  • compositions typically including at least one compound corresponding to the following formula (I) or (I’), referred to as "compound of thiopyridinone type”.
  • the present disclosure provides cosmetic compositions that are unique in comparison to conventional cosmetic compositions because they contain an association of compound of thiopyridinone type and a blend of natural emulsifiers, that show to be stable oil-in-water cosmetic compositions.
  • compositions of the instant disclosure typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I’) herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
  • R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ;
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 - C 12 or cyclic C 3 -C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C-i-C 8 alkoxy radicals; c) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals
  • R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; ii) at least two or more natural emulsifiers; and wherein the oil cosmetic composition is physically stable.
  • natural emulsifiers were able to effectively stabilize an o/w emulsion containing the newly developed raw material, compound of thiopyridinone type, with the same effectiveness as PEG-based emulsifiers.
  • Cosmetic formulations comprising the novel association that are appropriate for topical application to the skin include compositions having low viscosity such as lotion, serum, gel, gel cream.
  • natural refers to a compound or component that is obtained directly from the earth or soil or from plants or animals, via, if appropriate, one or more physical processes, such as grinding, refining, distillation, purification or filtration.
  • a "natural emulsifier” could still be subjected to a synthetic process.
  • 012-22 alkyl glucoside is not extracted from plants. It is made synthetically from 012-22 alcohols (which are extracted and separated from natural sources) and glucose (which is from natural sources). It is still considered completely “natural” because it is comprised of 100% natural components, even though the end result is made synthetically.
  • the term "natural”, as used herein is defined as having more than 80% w/w naturally occurring elements in the raw material.
  • the % naturality of RM is equal to molecular weight of naturally-occurring portions of molecule divided by total molecular weight of molecule.
  • sucrose laurate there are two components to synthesis this raw material: sucrose and lauric acid.
  • sucrose is 100% natural in that is extracted from sugar cane; thus 100% of carbons in the molecule are natural.
  • the lauric acid is 100% natural because it is derived from coconut; thus 100% of carbons in the molecule are natural. Even though a synthetic process is preformed to make sucrose laurate, 100% of the carbons that comprise the molecule came from natural sources.
  • Suitable components may be included or excluded from the formulations for the cosmetic compositions depending on the specific combination of other components, the form of the cosmetic compositions, and/or the use of the formulation (e.g., a lotion, a serum, gel, etc.).
  • Compounds Of Thionvridinone Type may be included or excluded from the formulations for the cosmetic compositions depending on the specific combination of other components, the form of the cosmetic compositions, and/or the use of the formulation (e.g., a lotion, a serum, gel, etc.).
  • a "saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 -C 12 ⁇ is equivalent to a “linear (C 1 -C 12 )alkyl or branched (C 3 -C 12 )alkyl group” which correspond to a saturated C 1 -C 12 linear or branched C 3 -C 12 hydrocarbon based group, and preferably C 1 -C 10 linear or C 3 -C 10 branched hydrocarbon based group, more preferably C 1 - C 3 linear or C 3 -C 6 branched hydrocarbon-based;
  • the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
  • the saturated linear or branched alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.
  • a saturated hydrocarbonated cyclic C 3 -C 8 group is a mono or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms especially is a monocyclic cycloalkyl group in C5 to C7 such as cyclohexyl group, an "alkoxy radical" is an alkyl-oxy radical for which the alkyl radical is a linear or branched C 1 -C 16 and preferentially C 1 -C 8 hydrocarbon-based radical;
  • an "aryl” group represents a fused or non-fused monocyclic or bicyclic carbon- based group comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one ring is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group ;
  • salts of the compounds of formula (I), (I'), (II) or (II’) as defined herein after comprise the conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acid or from organic or inorganic base.
  • salts of the compounds of formula (I), (I’), (II) or (II') mention may be made of : the salts obtained by addition of the compound of formula (I) or (II) to : a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example; or an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • a mineral base such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example
  • organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.
  • This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and/or oxygen atoms and may thus comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2-(hydroxymethyl)-1,3-propanediol and 3- (dimethylamino)propylamine.
  • salts of amino acids for instance lysine, arginine, guanidine, glutamic acid and aspartic acid.
  • the salts of the compounds of formula (I) or (II) may be chosen from alkali metal or alkaline-earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.
  • organic or inorganic acid salt is more particularly chosen from salts chosen from a salt derived from i) hydrochloric acid HCI, ii) hydrobromic acid HBr, iii) sulfuric acid -H 2 SO 4 iv) alkylsulfonic acids: Alk-S(O) 2 OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S(O) 2 OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-0-S(0)OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysul
  • the acceptable solvates of the compounds described in the instant disclosure comprise conventional solvates such as those formed during the preparation of said compounds owing to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
  • optical isomers are in particular, the enantiomers and the diastereoisomers.
  • the compounds used according to the instant disclosure therefore correspond to formula (I) or tautomer (I') below or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture.
  • R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -0-R 3 ii) -S-R 3 ;
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 12 or branched C 3 -C 12 or cyclic C 3 - C 8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -S-R 3 iii) -C(O)-O-R 3 ; iv) a C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals; c
  • the compound (I') is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
  • R 1 represents one hydrogen atom.
  • R1 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 3 )alkyl group or branched (C 3 -C 3 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl.
  • the said alkyl group of R 1 is not substituted.
  • R 2 represents one hydrogen atom.
  • R 2 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 3 )alkyl group or branched (C 3 -C 6 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group ; the said alkyl group of R 2 being not substituted.
  • R 2 represents a linear (C 1 -C 10 )alkyl group or branched (C 3 -C 10 )alkyl group, especially a linear (C 1 -C 6 )alkyl group or branched (C 3 -C 6 )alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i), ii), iii) and iv) as defined herein before.
  • the said alkyl group being substituted by one or two groups selected from I), ii) and iii), more preferably by one or two groups selected from i) and iii), better substituted by one group iii) as carboxy.
  • radical R 2 Another variant for radical R 2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
  • R 2 represents a (C 3 -C 8 )cycloalkyl group, preferably a (C 5 -C 7 )cycloalkyl group such cyclohexyl.
  • R 2 represents C 5 -C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 8 alkoxy radicals, preferably a phenyl group particularly not substituted.
  • R 3 represents a hydrogen atom.
  • R 3 represents a saturated linear C 1 -C 10 or branched C 3 -C 10 alkyl group; particularly a linear (C 1 -C 3 )alkyl group or a branched (C 3 -C 6 )alkyl group, preferably (C 1 -C 4 )alkyl group such as methyl group.
  • the compounds of formula (I) and tautomer (I') or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
  • Ri denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 6 or branched C 3 -C 3 alkyl group optionally substituted with one or more groups, which may be Identical or different, chosen from: i) -O-R 3 ii) -S-R 3 ; preferably optionally substituted with one or more groups i)
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 10 or branched C 3 -C 10 or cyclic C 3 - C 8 such as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 ii) -SR- 3 iii) -C(O)-O-R 3 ; iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 4 alkoxy radicals such as methoxy ; preferably substituted with one or more groups selected from I) and iii), preferably iii) such as carboxy
  • R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 3 or branched C 3 -C 3 alkyl group
  • the compounds
  • R 1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 4 or branched C 3 -C 4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR 3 .
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 10 or branched C 3 -C 10 or cyclic C 3 -C 8 as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R 3 iii) -C(O)-O-R 3 ; iv) a C5-C 12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C 1 -C 4 alkoxy radicals; R 3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C 1 -C 4 or branched C 3 -C 4 alkyl group such as methyl or ethyl .
  • the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
  • R 1 is a hydrogen atom
  • R 2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C 1 -C 5 or branched C 3 -C 5 or cyclic C 3 - C 8 as C5 -C6 , substituted with one or more groups, which may be identical or different, chosen from v) -C(O)-O-R3, preferably substituted with one group iii) -C(O)-O-R 3 ; R 2 is even more preferably a saturated hydrocarbonated group linear C 1 -C 4 or branched C 3 -C 4 substituted with one group iii) -C(O)-OR 3 .
  • compounds of formula (I) and tautomer are selected among compounds of formula (II) and also the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture :
  • R1 and R3 have the same meaning than for compounds of formula (I) and (I') and X denotes an alkylene radical -(CH 2 ) n - with n being an integer ranging inclusively from 1 to 10, preferably ranging from 1 to 6, more preferably ranging from 1 to 4, such as 1, preferably R 3 represents a hydrogen atom.
  • the following compounds are preferably used and their tautomer or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture:
  • the compound according to the instant disclosure is the following:
  • composition used according to the disclosure comprises at least one compound of formulae (I) and/or (II) as described above, in a physiologically acceptable medium.
  • the compound (I), (I'), (II) and/or (IP) may be present in the composition used according to the disclosure in an amount which may be between 0.01% and 10% by weight, preferably between 0.1% and 5% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.
  • the natural emulsifiers may be chosen from: Inulin Lauryl Carbamate, C 1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Cetearyl wheat straw glycosides and Cetearyl alcohol, Sorbitan Olivate, Glyceryl citrate stearate, Cetearyl Olivate (and) Sorbitan Olivate, other sucrose and glucose esters and ethers, amino acid-based emulsifiers, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
  • Suitable hydrophobically-modifled natural emulsifiers include, for example, inulin lauryl carbamate, commercially available from Beneo Orafti under the tradename Inutec SP1.
  • Suitable natural emulsifiers with an HLB around about 10 include, but are not limited to, polyglycerides and mixture thereof.
  • the fatty add esters of a sugar that can be used as non ionic amphiphilic lipids can be chosen in particular from the group comprising esters or mixtures of esters of a C8-C22 fatty acid and of sucrose, of maltose, of glucose or of fructose, and esters or mixtures of esters of a C 1 4-C22 fatty acid and of methylglucose.
  • the C8-C22 or C 1 4- C22 fatty acids forming the fatty unit of the esters that can be used in the emulsion comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms.
  • the fatty unit of the esters can be chosen in particular from stearates, behenates, arachidonates, palmitates, myristates, laurates, caprates and mixtures thereof.
  • esters or of mixtures of esters of a fatty acid and of sucrose, of maltose, of glucose or of fructose mention may be made of sucrose monostearte, sucrose distearate, sucrose tristearate and mixtures thereof, such as the products sold by the company Croda under the name Crodesta F50, F70, F1 10 and F160 having, respectively, an HLB (Hydrophilic Lipophilic Balance) of 5, 7, 1 1 and 16; and, by way of example of esters or of mixtures of esters of a fatty acid and of methylglucose, mention may be made of the disearate of methylglucose and of polyglycerol-3, sold by the company Goldschmidt under the name Tego-care 450. Mention may also be made of glucose monoesters or maltose monoesters, such as methyl O-hexadecanoyl-6-D-glucoside and O-hexadecanoyl-6-D
  • the fatty alcohol ethers of a sugar that can be used as nonionic amphiphilic lipids can be chosen in particular form the group comprising ethers or mixtures of ethers of a 08-022 fatty alcohol and of glucose, of maltose, of sucrose or of fructose, and ethers or mixtures of ethers of a C 4-C22 fatty alcohol and of methylglucose. They are in particular alkylpolyglucosides.
  • the C8-C22 or C 1 4-C22 fatty alcohols forming the fatty unit of the ethers that can be used in the emulsion of the instant disclosure comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms.
  • the fatty unit of the ethers can be chosen in particular from decyl, cetyl, behenyl, arachidyl, stearyl, palmityl, myristyl, lauryl, capryl and hexadecanoyl units, and mixtures thereof such as cetearyL
  • alkylpolyglucosides such as decylglucoside and laurylglucoside sold, for example, by the company Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearylglucoside, optionally as a mixture with cetostearyl alcohol, sold, for example, under the name Montanov 68 by the company Seppic, under the name Tego-care CG90 by the company.
  • Use is more particularly made, as nonionic amphiphilic lipid of this type, of sucrose monostearate, sucrose distearate, sucrose tristearate and mixtures thereof, the distearate of methylglucose and of polyglycerol-3, and alkylpolyglucosides.
  • the natural emulsifiers having an HLB from around about 10 to about 15 will typically be employed in an amount of from about 0.5 to about 8 wt%, based on the total weight of the composition.
  • the total amount of natural emulsifier present in the compositions is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
  • the natural emulsifiers may be chosen from one or more polyglyceryl fatty acid ester having an HLB value of 8.0 or more, preferably 8.5 or more, and more preferably 9.0 or more.
  • a single type of polyglyceryl fatty acid ester may be used, but two or more different types of first polyglyceryl fatty acid ester may be used in combination.
  • the one or more polyglyceryl fatty acid ester may have an HLB value of from 8.0 to 20.0, preferably from 8.5 to 18, and more preferably from 9.0 to 14.0.
  • HLB hydrophilic-lipophilic balance
  • the one or more polyglyceryl fatty acid ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
  • the one or more polyglyceryl fatty acid ester comprises 2 to 4 glycerol units, preferably 3 or 4 glycerol units, and more preferably 4 glycerol units.
  • the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 12 or fewer carbon atoms, preferably 11 or fewer carbon atoms, and more preferably 10 or fewer carbon atoms.
  • the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 4 or more carbon atoms, preferably 6 or more carbon atoms, and more preferably 8 or more carbon atoms.
  • the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have carbon atoms of from 4 to 12, preferably from 6 to 11, and more preferably from 8 to 10 carbon atoms.
  • the fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from caprylic acid, capric acid, and lauric acid.
  • the one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), PG5 myristate (HLB: 15.4), PG5 stearate (HLB: 15), PG-5 oleate (HLB 11.5), PG6 caprylate (HLB: 14.6), PG6 caprate (HLB: 13.1), PG6 laurate (HLB: 14.1), PG10 laurate (HLB: 15.2), PG10 myristate (HLB: 14.9), PG10 stearate (HLB: 14.1), PG10 isostearate (HLB: 13.7), PG-10 diisostearate (HLB: 11), PG10 oleate (HLB: 13.0), PG10 cocoate (HLB: 16), and mixtures thereof.
  • the one or more polyglyceryl fatty add ester(s) be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), and mixtures thereof.
  • the one or more polyglyceryl fatty add ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
  • the fatty add for the fatty add moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 14 or more carbon atoms, preferably 16 or more carbon atoms, and more preferably 18 or more carbon atoms.
  • the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty add ester may comprise 30 or fewer carbon atoms, preferably 24 or fewer carbon atoms, and more preferably 20 or fewer carbon atoms.
  • the fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have from 14 to 30, preferably from 16 to 24, and more preferably from 18 to 20 carbon atoms.
  • the fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from myristic acid, stearic acid, isostearic acid, and oleic acid.
  • the one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), PG6 distearate (HLB: 8), PG10 distearate (HLB: about 9), PG10 tristearate (HLB: 8), PG10 diisostearate (HLB: 10), PG10 triisostearate (HLB: 8), PG10 tricocoate (HLB: 9), and mixtures thereof.
  • PG2 sesquicaprylate HLB: about 8
  • PG2 caprate HLB: 9.5
  • PG2 laurate
  • the one or more polyglyceryl fatty acid be selected from the group consisting of PG2 isostearate (HUB: 8), PG2 oleate (HLB: 8), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), and mixtures thereof.
  • the one or more polyglyceryl fatty acid ester mention may be made of Sunsoft® Q-17D(G) from Taiyo Kagaku Co., Ltd., Sunsoft® A-121 E-C from Taiyo Kagaku Co., Ltd., and Tegosoft® PC 41 from Evonik Co., Ltd.
  • the amount of the one or more polyglyceryl fatty acid ester(s) in the composition according to the Instant disclosure may be from about 0.5 to about 3 wt.% based on the total weight of the cosmetic composition.
  • the total the one or more polyglyceryl fatty acid esters) in the composition is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
  • a log P value is a value for the base-ten logarithm of the apparent octan-1- ol/water partition coefficient.
  • the log p values are known and are determined by a standard test which determines the concentration of the (c) compound in octan-1-ol and water.
  • the log P may be calculated according to the method described in the article by Meylan and Howard: Atom/Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84: 83-92, 1995. This value may also be calculated using numerous commercially available software packages, which determine the log P as a function of the structure of a molecule. By way of example, mention may be made of the Epiwin software from the United States Environmental Agency.
  • the values may especially be calculated using the ACD (Advanced Chemistry Development) Solaris software V4.67; they may also be obtained from Exploring QSAR: hydrophobic, electronic and steric constants (ACS professional reference book, 1995). There is also an Internet site which provides estimated values (address: http://esc.syrres.com/interkow/kowdemo.htm).
  • composition may also include Vitamin B3 and derivatives.
  • Vitamin B3 also called vitamin PR, is a compound of the following formula: in which R may be -CONH2 (niacinamide), -COOK (nicotinic acid or niacin), or CH2OH (nicotinyl alcohol), -CO-NH-CH2-COOH (nicotinuric acid) or -CO-NH-OH (niconityl).
  • the cosmetic compositions include an oil phase comprising one or more oils.
  • the amount of oil phase e.g., the total amount of oils
  • the cosmetic composition includes oils that are plant based or vegetable based oils.
  • the amount of oils present in the cosmetic composition may be from about 0.5 to about 40 wt%, about 0.5 to about 38 wt%, about 0.5 to about 34 wt.%, about 0.5 to about 32 wt.%; 0.5 to about 30 wt.%, 0.5 to about 28 wt.%, 0.5 to about 26 wt.%, 0.5 to about 24 wt.%, about 1 to about 40 wt.%, 1 to about 38 wt.%, 1 to about 36 wt.%, 1 to about 34 wt.%, 1 to about 32 wt.%, 1 to about 30 wt.%, 1 to about 28 wt.%, 1 to about 26 wt.%, 1 to about 24 wt.%, about 2 to about 40 wt.%, 2 to about 38 wt.%, 2 to about 36 wt.%, 2 to about 34 wt%, 2 to about 32 wt.%, 2 to about 30 wt.%, 2
  • the cosmetic composition may exclude synthetic oils.
  • the cosmetic composition may exclude oils other than plant based and vegetable based oils.
  • the amount of synthetic oils and/or oils other than plant based and vegetable based oil may be about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less, based on the total weight of the cosmetic composition.
  • the cosmetic composition is free of or essentially free of synthetic oils and/or oils other than plant based and vegetable based oil.
  • oil means any fatty substance which is in liquid form at room temperature (20-25°C.) and at atmospheric pressure (760 mmHg). Often, at least one of the oils in the cosmetic composition is part of an oily phase.
  • An "oily phase” is a phase comprising at least one oil that may include additional liposoluble and lipophilic ingredients and the fatty substances. Oil that is suitable for use herein may be volatile or non-volatile.
  • volatile oil relates to an oil that is capable of evaporating on contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure.
  • Volatile oil(s) are liquid at room temperature and have a nonzero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40 000 Pa (10-3 to 300 mmHg).
  • non-volatile oil relates to an oil that remains on the skin or the keratin fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10-3 mmHg (0.13 Pa).
  • composition according to the present invention may comprise at least one pH adjusting agent (pH adjuster). Two or more pH adjusting agents may be used in combination. Thus, a single type of pH adjusting agent or a combination of different types of pH adjusting agents may be used.
  • At least one acidifying agent and/or at least one basifying agent may be used.
  • the acidifying agent may be a monovalent or polyvalent, such as divalent, acid.
  • the acidifying agents can be, for example, mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid, or organic acids such as carboxylic acids, for instance tartaric acid, citric acid, and lactic acid, as well as sulphonic acids.
  • mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid
  • organic acids such as carboxylic acids, for instance tartaric acid, citric acid, and lactic acid, as well as sulphonic acids.
  • the basifying agent may be a monovalent or polyvalent, such as divalent, base.
  • the basifying agents may be mineral (inorganic) or organic, or hybrid.
  • the mineral basifying agents may be chosen from aqueous ammonia; alkali metal carbonates or bicarbonates such as sodium or potassium carbonates and sodium or potassium bicarbonates; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; and mixtures thereof.
  • the organic basifying agents may be chosen from organic amines with a pKb at 25°C of less than 12, preferably less than 10, and even more advantageously less than 6. It should be noted that it is the pKb corresponding to the function of highest basicity.
  • the organic amines do not comprise any alkyl or alkenyl fatty chains comprising more than ten carbon atoms.
  • the organic basifying agent may be chosen, for example, from akanolamines, oxyethylenated and/or oxypropylenated ethylenediamines, amino acids and amine compounds of formula (III) below: in which
  • W represents a C 1 -C 6 divalent alkylene radical optionally substituted with one or more hydroxyl groups or a C 1 -C 8 alkyl radical, and optionally interrupted with one or more heteroatoms such as O and N, and
  • R x , R y , R z , and Rt which may be identical or different, represent a hydrogen atom or a C 1 -C 3 alkyl, C 1 -C 3 hydroxyalkyl, or C 1 -C 3 aminoalkyl radical.
  • Examples of the amine compounds of formula (III) that may be mentioned include 1,3- diaminopropane, 1 ,3-diamino-2-propanol, spermine and spermidine.
  • alkanolamine means an organic amine comprising a primary, secondary or tertiary amine function, and one or more linear or branched C 1 -C 8 alkyl groups bearing one or more hydroxyl radicals.
  • Alkanolamines such as monoalkanolamines, dialkanolamines or trialkanolamines comprising one to three identical or different C 1 -C 4 hydroxyalkyl radicals may be suitable for the present invention.
  • monoethanolamine MEA
  • diethanolamine triethanolamine
  • monoisopropanolamine diisopropanolamine
  • diisopropanolamine N-dimethylaminoethanolamine
  • 2-amino- 2-methyl-1 -propanol triisopropanolamine
  • 2-amino-2-methyl-1,3-propanediol 3-amino- 1 ,2-propanediol, 3-dimethylamino-1,2-propanediol and tris(hydroxymethylamino)methane.
  • Amino acids that may be used are of natural or synthetic origin, in their L, D or racemic form, and comprise at least one acid function chosen more particularly from carboxylic acid, sulfonic acid, phosphonic acid or phosphoric acid functions.
  • the amino acids may be in neutral or ionic form.
  • amino acids that may be used in the present invention, mention may be made especially of aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleuclne, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine and valine.
  • amino acids are basic amino acids comprising an additional amine function optionally included in a ring or in an ureido function.
  • Such basic amino acids may preferably be chosen from those corresponding to formula (IV) below: in which
  • R represents a group chosen from:
  • the compounds corresponding to formula (IV) include histidine, lysine, arginine, ornithine and citrulline.
  • the organic basifying agent may be chosen from organic amines of heterocyclic type. Besides histidine that has already been mentioned in the amino adds, mention may in particular be made of pyridine, piperidine, imidazole, triazole, tetrazole and benzimidazole.
  • the organic basifying agent may also be chosen from amino acid dipeptides.
  • amino acid dipeptides that may be used in the present invention, mention may be made especially of camosine, anserine and baleine.
  • the organic basifying agent may also be chosen from compounds comprising a guanidine function.
  • amines of this type that may be used in the present invention, besides arginine, which has already been mentioned as an amino acid, mention may be made especially of creatine, creatinine, 1,1-dimethylguanidine, 1,1-diethyl-guanidine, glycocyamine, metformin, agmatine, N-amidinoalanine, 3-guanidino-propionic acid, 4- guanidinobutyric acid and 2-([amino(imino)methyl]amino)ethane-1 -sulfonic acid.
  • the organic basifying agent may be selected from amino acids, preferably basic amino acids, and more preferably arginine, lysine, histidine or mixtures thereof. Even more preferentially, the organic basifying agent may be arginine.
  • Hybrid compounds that may be mentioned include the salts of the amines mentioned previously with acids such as carbonic acid or hydrochloric acid. Guanidine carbonate or monoethanolamine hydrochloride may be used in particular.
  • the pH adjusting agent may be present in an amount of 0.01 % by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
  • the pH adjusting agent may be present in an amount of 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.
  • the pH adjusting agent may be present in an amount ranging from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight, and more preferably from 0.1% to 5% by weight or less, relative to the total weight of the composition.
  • composition according to the present invention have a pH of 4.5 or more, and more preferably 5 or more.
  • composition according to the present invention have a pH of 6.5 or less, and more preferably 6 or less.
  • composition according to the present invention have a pH of from 4.5 to 6.5, and more preferably from 5 to 6.
  • the pH of the composition means the pH of the aqueous phase of the composition according to the present invention.
  • At least one buffer or buffering agent also be used, as the pH adjusting agent, in combination with the acidifying agent and/or the basifying agent, in order to stabilize the pH of the composition according to the present invention.
  • any of commonly known buffers may be used.
  • salts of acids or bases preferably salts of weak acids or weak bases, may be used.
  • sodium citrate or sodium lactate may be used as the buffer, if citric acid or lactic acid is used as the acidifying agent.
  • the cosmetic compositions include a cosmetically acceptable carrier system.
  • cosmetically acceptable means a earner that is compatible with any keratinous substrate, and for purposes hereof, includes water and optionally water based solvents subject to any exclusions as disclosed herein.
  • the cosmetic compositions may comprise any constituent normally employed in the topical application and administration envisaged. Mention may in particular be made of water, solvents, fatty compounds (i.e. described by the International Federation Societies of Cosmetic Chemists, for example, in Cosmetic Raw Material Analysis and Quality, Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994), which is incorporated herein by reference in its entirety), polyols, pigments, fillers, silicones, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
  • fatty compounds i.e. described by the International Federation Societies of Cosmetic Chemists, for example, in Cosmetic Raw Material Analysis and Quality, Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994), which is incorporated herein by reference in its entirety
  • polyols pigments
  • fillers silicones
  • surfactants thickeners
  • gelling agents preservatives and their mixtures
  • the composition may be in the form of macroemulsion.
  • Macroemulsions are dispersed liquid-liquid, thermodynamically unstable systems with particle sizes ranging from 1 to 100 pm (orders of magnitude), which, most often, do not form spontaneously. Macroemulsions scatter light effectively and therefore appear milky, because their droplets are greater than a wavelength of light.[1] They are part of a larger family of emulsions along with miniemulsions (or nanoemulsions). As with all emulsions, one phase serves as the dispersing agent. It is often called the continuous or outer phase.
  • the remaining phase(s) are disperse or inner phase(s), because the liquid droplets are finely distributed amongst the larger continuous phase droplets.
  • This type of emulsion is thermodynamically unstable, but can be stabilized for a period of time with applications of kinetic energy.
  • Surfactants as the main emulsifiers
  • Emulsions can be stabilized otherwise with polymers, solid particles (Pickering emulsions) or proteins.
  • the macroemulsion may have a dispersed phase with a particle size of no less than 600 nm total as minimum of range. Most likely in micron range, such as 0.8 to 20 microns. They do not form spontaneously (like microemulsions do).
  • the OA/V architecture or structure which consists of oil phases dispersed in an aqueous phase, has an external aqueous phase, and therefore if the composition according to the Instant disclosure has the O/W architecture or structure, it can provide a pleasant feeling during use because of the feeling of immediate freshness that the aqueous phase can provide.
  • the particle size can be measured by a dynamic light scattering method.
  • the particle size measurement can be performed by, for example, the Particle Size Analyzer ELSZ-2000 series, marketed by Otsuka Electronics Co., Ltd.
  • the particle size can be a volume-average particle diameter or a numberaverage particle diameter, preferably a volume-average particle diameter.
  • the instant disclosure also relates to methods of using the cosmetic compositions described herein.
  • the cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans. In some cases, the composition is applied to the face.
  • the cosmetic composition can be used in methods for depigmenting and/or bleaching keratin materials, preferably skin, comprising the step of: applying to the keratin substance the composition according to the compositions described herein. The aforementioned methods are non-therapeutic.
  • the instant disclosure also relates to non-therapeutic cosmetic process for depigmenting, lightening and/or bleaching keratin materials, preferably skin, comprising the step of applying to the keratin substance the composition according to the compositions described herein.
  • the cosmetic composition may be applied once per day, twice per day, or more than once or twice per day. In some cases, the composition is applied in the evenings before bed. In other cases, the compositions are applied in the morning. In still other cases, the composition may be applied immediately after washing the skin.
  • the compositions may be used once, or for a series of days, weeks, or months. For example, the compositions may be used daily for a period of 1 , 2, 3, 4, 5, 6, 7, 8 or more weeks, or months.
  • Another aspect of the instant disclosure relates to a use of: a. One or more Polyglyceryl Fatty Acid Ester; for enhancing or improving the skin penetration of b. Compound of thlopyridinone type; in a composition in the form of a macroemulsion comprising: c. One or more oils.
  • Compound 20 is synthesized as disclosed in example 2 of patent EP3390363.
  • compositions were prepared using the following general procedure:
  • the water soluble raw materials (minus actives) were added to the main kettle and dissolved. Polymers were then added and mixed until well-dispersed. Batch was heated to 75C. In a side kettle, the fatty compounds, silicones, and emulsifiers/surfactants were mixed together and heated to 75C. The side kettle was added to the main kettle while homogenizing well. When well emulsified, the batch was cooled to room temperature, and actives and fillers were added.
  • inventive Examples and Comparative Examples were tested for stability.
  • the stability of the inventive and comparative Examples was assessed by following the procedure described below.
  • 1 means the emulsion is stable and homogenous during and soon after processing, and is also stable after at least 2 months at 25’C and 45°C.
  • 2 could be anything from product being not homogenous in texture to after formulation to noticeable separation of phases after 2 weeks at 25°C and/or 45°C
  • THP stable, direct emulsions containing THP, using natural emulsifiers, rather than PEG-containing emulsifiers, which are mainly synthetic emulsifiers.
  • natural emulsifiers rather than PEG-containing emulsifiers, which are mainly synthetic emulsifiers.
  • THP could be included into a physically stable high viscosity emulsion containing more than 15% of fatty acids.
  • having a slightly lower viscosity emulsion would allow for many more architectures with vastly different sensorial attrfoutes. Thinner creams, lotions, and serums containing THP could be developed with natural emulsifiers, while remaining stable and sensorial.
  • compositions were prepared using the general procedure described above.
  • Inventive Examples and Comparative Examples were tested to measure the enhanced penetration of the active ingredients.
  • the enhanced penetration of the inventive and comparative Examples was assessed by following the procedure described below.
  • the penetration test experiments were performed in a Franz diffusion cell (Hanson) with a Strat-M membrane (Millipore, diameter of 15 mm).
  • This equipment was composed of a donor part and a receptor part with the Strat-M membrane between the donor and receptor parts.
  • the receptor part with a predetermined volume was filled with a receiving solution (0.25 wt.% Tween 80/deionized water) maintained at a temperature of 32 °C, which was continuously stirred with a small magnetic bar.
  • a receiving solution (0.25 wt.% Tween 80/deionized water) maintained at a temperature of 32 °C, which was continuously stirred with a small magnetic bar.
  • Each of the compositions according to Examples 3-5 and Comparative Examples 3-6 was spread with a spatula on the membrane of the donor part with an amount of 30 mg/cm2.
  • the receiving solution was withdrawn from the receptor part, while providing the same amount of a new receiving solution to the receptor part to maintain the same penetration conditions.
  • the withdrawn receiving solution was analyzed by HPLC to determine the amount of the active ingredient in the receiving solution.
  • the percentage of the active ingredient that passed through the membrane was calculated by dividing the detected amount of the active ingredient in the receiving solution by the amount of the active ingredient spread on the membrane.
  • the amount of active in the cell was then plotted over time to determine the speed of diffusion through the membrane, as well as the total amount diffused after 24 hrs.
  • penetration enhancers were studied (i.e. Ethoxydiglycol, Dimethyl isosorbide, Sodium dilauramidoglutamide lysine as well as other raw materials that are not knowns to be penetration enhancers (i.e. Laureth-4 and polyglyceryl-4 caprate).
  • Figure 1 and Figure 2 represented the percentage of the penetration of the thiopyridinone compound (i.e. THP) through the membrane over time.
  • the Base Formula started to penetrate through the membrane within the hour and kept increasing overtime up to a plateau after 24 hours.
  • the base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
  • Comp. Ex. 3 and Comp. Ex. 4. showed that the penetration of the THP was slow as well at the beginning. In the case of Comp. Ex. 4, it was even observed that the penetration of the thiopyridinone compound was very limited over time. In the case of Comp. Ex. 3, the penetration increased slowly and reached a plateau as well, but still the penetration didn't reach the high level reached with the base formula. Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
  • Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4.
  • the penetration of the thiopyridinone compound was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau.
  • Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
  • the Inventive Ex. 3 demonstrated that the penetration of the thiopyridinone compound was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours.
  • the inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
  • Figure 3 and Figure 4 represented the percentage of the penetration of Niacinamide through the membrane overtime.
  • the Base Formula started to penetrate through the membrane within the hour and kept increasing over time up to a plateau after 24 hours.
  • the base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
  • Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4.
  • the penetration of the niacinamide was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau.
  • All Comparative Examples didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
  • the Inventive Ex. 4 demonstrated that the penetration of niacinamide was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours.
  • the inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
  • At least one means one or more and thus includes individual components as well as mixtures/combinations.
  • free and “devoid” indicates that no reliably measurable excluded material is present in the composition, typically 0% by weight, based on the total weight of the composition.
  • essentially free means that, while it prefers that no excluded material is present in the composition, it is possible to have very small amounts of the excluded material in the composition of the disclosure, provided that these amounts do not materially affect the advantageous properties of the canposition.
  • essentially free means that excluded material can be present in the composition at an amount of less than about 0.1% by weight, based on the total weight of the composition.
  • weight percent of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material.
  • weight percent and “wt%” may be used interchangeably and mean percent by weight, based on the total weight of a composition, article or material, except as may be specified with respect to, for example, a phase, or a system that is a component of a composition, article or material. All ranges and amounts given herein are intended to include subranges and amounts using any disclosed point as an end point. Thus, a range of "1% to 10%, such as 2% to 8%, such as 3% to 5%,” is intended to encompass ranges of "1% to 8%,” “1% to 5%,” “2% to 10%,” and so on. All numbers, amounts, ranges, etc., are intended to be modified by the term “about,” whether or not so expressly stated.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The instant disclosure relates to cosmetic compositions comprising a combination of a blend natural emulsifiers and compound of thiopyridinone type wherein the cosmetic compositions are physically stable and provide enhanced penetration of actives into skin. The instant disclosure also provides methods of use related thereto.

Description

COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims benefit of U.S. Non Provisional Application No. 17/844,930, filed Jun 21, 2022, U.S. Non Provisional Application No. 17/844,949, filed Jun 21 , 2022, French Patent Application No. 2211483, filed November 4, 2022 and French Patent Application No. 2211482, filed November 4, 2022, which are Incorporated herein by reference in their entirety.
FIELD OF THE DISCLOSURE
The present disclosure relates to cosmetic compositions comprising a combination of natural emulsifiers and compound of thiopyridlnone type.
BACKGROUND OF THE DISCLOSURE
It has always been an ultimate target off the cosmetic filed to deliver products with skin benefits such as hydration, moisturizing, antl-aglng, whitening, deanring, and so on. Whitening and brightening of the skin is always high Interest of the consumers, especially those who have a dark or dull skin tone. Unfortunately, at various periods of their life, some people see the appearance on their skin, and more in particular on the hands, of darker and/or more colored spots, which give the skin heterogeneity. These spots are in particular due to a high concentration of melanin in the keratinocytes located at the surface of the skin.
Accordingly, there is a need In the art for cosmetic composition that offers stable formulation that indudes actives for brightening ridn and reducing dark spots, or a combination of these. It Is preferable for ridn care active Ingredients to be absorbed by the ridn or penetrated into the skin as much as possible. However, ridn absorption or ridn penetration of such ridn care active Ingredients Is not easy due to the barrier function of the skin. Thus, one possible approach to enhance the ridn penetration of a skin care active ingredient may be to use a skin penetration enhancer with the skin care active ingredient.
SUMMARY OF THE DISCLOSURE
The present disclosure relates to stable oil-in-water cosmetic compositions comprising compound of thiopyridinone type and a blend of natural emulsifiers. The cosmetic compositions have low viscosity. The compositions described in the instant disclosure are unique in comparison to other traditional oil-in-water compositions that contain emulsifiers containing PEG groups that offer the greatest flexibility and stability when formulating because of the oligomeric nature of the molecules. However, with concerns about naturality obtaining emulsion stability using more naturally-derived molecules can prove useful. In contrast to mainly PEG-based and other synthetic emulsifiers, natural-based emulsifiers are in far fewer number. Moreover, they do not have the same advantages as the aforementioned oligomeric emulsifiers. Natural emulsifiers are often more difficult to formulate with, but they have benefits of naturality.
The inventors have discovered that the inclusion of a combination of compound of thiopyridinone type (I) or (I') and a blend of natural emulsifiers surprisingly stabilize oil-in-water cosmetic compositions and in some cases would enhance the penetration of the compound of thioprydinone type. The oil-in-water cosmetic composition typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture:
Figure imgf000003_0001
In which Formulas (I) and (I') : - R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 ;
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3- C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals
- R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; ii) at least two or more natural emulsifiers; and wherein the oil-in-water cosmetic composition is physically stable. In some embodiments, the oil-in-water composition might comprise one or more Polyglyceryl Fatty Acid Ester. In some other embodiments, the oil-in-water might comprise one or more oils. I
In some embodiments, the compound i) is typically present in the cosmetic compositions in an amount of from about 0.01 to about 10 wt.%, based on the total weight of the cosmetic composition. In some cases, the amount of compound I) is present in an amount of from about 0.1 to about 5 wt.%, based on the total weight of the cosmetic composition. In some embodiments, the compound i) is typically present in the cosmetic compositions in an amount of from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
In some embodiments, the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have intermediate to high HLB. In some embodiments, the cosmetic compositions may include a blend of at least two or more natural emulsifiers that have a HLB from about 10 to about 15. In one or more embodiments, the at least two or more natural emulsifiers has a HLB from about 10 to about 15. In some embodiments, the cosmetic composition may include at least two or more natural emulsifiers selected from the group consisting of inulin lauryl carbamate, C1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof. In one embodiment, the at least two or more natural emulsifiers is inuline carbamate.
In some embodiments, the cosmetic composition may include one or more Polyglyceryl Fatty Acid Ester. In some embodiments, the one or more Polyglyceryl Fatty Acid Ester have an HLB from about 8 to about 20. In various embodiments, the polyglyceryl fatty acid esters has a polyglyceryl moiety derived from 2 to 10 glycerins, preferably 2 to 8 glycerins, and more preferably from 2 to 6 glycerins. In one or more embodiments, the one or more polyglyceryl fatty acid ester Is chosen from polyglyceryl monolaurate comprising 2 to 6 glycerol units, polyglyceryl monocaprate comprising 2 to 6 glycerol units, polyglyceryl monooleate comprising 2 to 6 glycerol units, and polyglyceryl distearate comprising 2 to 6 glycerol units. In some embodiments, the one or more polyglyceryl fatty acid esters is selected from the group consisting of polyglyceryl-4 caprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dioleate, polyglyceryl-6 distearate, and mixtures thereof. In one or more embodiments, the one or more polyglyceryl fatty acid esters is present from about 0.5 to about 3 wt.%, based on the total weight of the cosmetic composition.
In various embodiments, the composition provides enhanced penetration of the i) compound of thiopyridinone type in an in vitro penetration test.
In some embodiments, the at least two or more natural emulsifiers are present from about 0.3 to about 6 wt.%, based on the total weight of the cosmetic composition. In one or more embodiments, the sucrose have an intermediate to high HLB.
In some embodiments, the i) compound of thiopyridinone type has a logP value ranging from about -1.5 to about 1.5.
In some other embodiments, the cosmetic composition might comprise one or more oils.
In some embodiments, the cosmetic compositions may include non-natural emulsifiers.
In some embodiments, the cosmetic compositions may include one or more thickening polymers.
In some embodiments, the cosmetic compositions may include one or more fatty compounds.
In some embodiments, the cosmetic composition has a low viscosity.
In some embodiments, the cosmetic compositions may include inulin lauryl carbamate that can be present from about 0.2 wt.% to about 3 wt.%, based on the total weight of the cosmetic composition. In one or more embodiments, the cosmetic composition may have a pH ranging from about 4.5 to about 6.5, preferably from about 5 to about 6.
In one or more embodiments, the cosmetic composition may include:
I) from about 0.01 to about 10 wt.% of at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
Figure imgf000007_0001
In which Formulas (I) and (I') :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 ;
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3- C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals
- R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; ii. about 0.5 to about 2 wt.% of at least two or more natural emulsifiers that are elected from the group consisting of inulin lauryl carbamate, C12 -20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyi Alcohol (And) Behenyl Alcohol (And) Arachidyi Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof. wherein the weight percentages are based on the total weight of the cosmetic composition.
In some embodiments, the cosmetic compositions may include: i) from about 0.01 to about 10 wt.% of at least one compound selected from compounds of formula (I) and tautomer of formula (I') herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
Figure imgf000009_0001
In which Formulas (I) and (I') :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1 -C1 0 or branched C3 -C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from:
I) -O-R3 ii) -S-R3 ;
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1 -C12 or branched C3-C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1 -C8 alkoxy radicals - R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1 -C10 or branched C3-C10 alkyl group; li) about 0.5 to about 3 wt.% of one or more Polyglyceryl Fatty Add Ester with a HLB from about 8 to about 20; iii) one or more oil; and wherein the cosmetic composition is a macroemulsion and wherein the penetration of the i) compound of thiopyridinone type is rapid and enhanced.
The cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans. In some embodiments, the cosmetic composition provides enhanced penetration of the compound of thiopyridinone type into skin.
It was proven that natural emulsifiers were able to effectively stabilize an o/w emulsion containing the newly developed raw material, compound of thiopyridinone type, with the same effectiveness as PEG-based emulsifiers.
Another aspect of the instant disclosure is methods of increasing the percentage of the compound of thiopyridinone type deposited in skin, the method comprising topically applying the cosmetic composition of the instant disclosure to skin, wherein the cosmetic composition of the instant disclosure increases the percentage of the compound of thiopyridinone type deposited in the skin.
These and other aspects of the disclosure are set out in the appended claims and described in greater detail in the detailed description of the disclosure.
This disclosure describes exemplary embodiments in accordance with the general inventive concepts and is not intended to limit the scope of the disclosure in any way. Indeed, the disclosure as described in the specification is broader than and unlimited by the exemplary embodiments set forth herein, and the terms used herein have their full ordinary meaning.
BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Base Formula and Comparative Examples.
FIG.2 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
FIG.3 is a graph showing the percentage of applied Niacinamide penetration for Base Formula and Comparative Examples.
FIG.4 is a graph showing the percentage of applied compound of thiopyridinone type (THP) penetration for Inventive and Comparative Examples.
It should be understood that the various aspects of the present disclosure are not limited to the arrangements and instrumentality shown in the figures.
DETAILED DESCRIPTION OF THE DISCLOSURE
The present disclosure relates to cosmetic compositions typically including at least one compound corresponding to the following formula (I) or (I’), referred to as "compound of thiopyridinone type".
The present disclosure provides cosmetic compositions that are unique in comparison to conventional cosmetic compositions because they contain an association of compound of thiopyridinone type and a blend of natural emulsifiers, that show to be stable oil-in-water cosmetic compositions.
The cosmetic compositions of the instant disclosure typically include: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I’) herein below; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
Figure imgf000011_0001
In which Formulas (I) and (I’) : - R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 ;
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3- C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C-i-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals
- R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; ii) at least two or more natural emulsifiers; and wherein the oil cosmetic composition is physically stable. The inventors have discovered that natural emulsifiers were able to effectively stabilize an o/w emulsion containing the newly developed raw material, compound of thiopyridinone type, with the same effectiveness as PEG-based emulsifiers.
Cosmetic formulations comprising the novel association that are appropriate for topical application to the skin include compositions having low viscosity such as lotion, serum, gel, gel cream.
The term "natural," as used herein refers to a compound or component that is obtained directly from the earth or soil or from plants or animals, via, if appropriate, one or more physical processes, such as grinding, refining, distillation, purification or filtration. A "natural emulsifier" could still be subjected to a synthetic process. For example, 012-22 alkyl glucoside is not extracted from plants. It is made synthetically from 012-22 alcohols (which are extracted and separated from natural sources) and glucose (which is from natural sources). It is still considered completely “natural" because it is comprised of 100% natural components, even though the end result is made synthetically.
The term "natural", as used herein is defined as having more than 80% w/w naturally occurring elements in the raw material. Generally, the % naturality of RM is equal to molecular weight of naturally-occurring portions of molecule divided by total molecular weight of molecule. For example, if we look at sucrose laurate as a general example, there are two components to synthesis this raw material: sucrose and lauric acid. The sucrose is 100% natural in that is extracted from sugar cane; thus 100% of carbons in the molecule are natural. Likewise, the lauric acid is 100% natural because it is derived from coconut; thus 100% of carbons in the molecule are natural. Even though a synthetic process is preformed to make sucrose laurate, 100% of the carbons that comprise the molecule came from natural sources.
Suitable components, such as those listed below, may be included or excluded from the formulations for the cosmetic compositions depending on the specific combination of other components, the form of the cosmetic compositions, and/or the use of the formulation (e.g., a lotion, a serum, gel, etc.). Compounds Of Thionvridinone Type
For the purposes of the instant disclosure, and unless otherwise indicated:
■ a "saturated hydrocarbonated group linear C1-C12 or branched C3-C12● is equivalent to a “linear (C1-C12)alkyl or branched (C3-C12)alkyl group” which correspond to a saturated C1-C12 linear or branched C3-C12 hydrocarbon based group, and preferably C1-C10 linear or C3-C10 branched hydrocarbon based group, more preferably C1- C3 linear or C3-C6 branched hydrocarbon-based; Preferentially, the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.
More preferentially, the saturated linear or branched alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.
■ a saturated hydrocarbonated cyclic C3-C8 group is a mono or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms especially is a monocyclic cycloalkyl group in C5 to C7 such as cyclohexyl group, an "alkoxy radical" is an alkyl-oxy radical for which the alkyl radical is a linear or branched C1-C16 and preferentially C1-C8 hydrocarbon-based radical;
■ when the alkoxy group is optionally substituted, this implies that the alkyl group is optionally substituted as defined hereinabove; an "aryl" group represents a fused or non-fused monocyclic or bicyclic carbon- based group comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one ring is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl, more preferably a phenyl group ;
■ the term "at least one" is equivalent to the term "one or more"; and
■ the term "inclusive" for a range of concentrations means that the limits of that range are included in the defined range. The salts of the compounds of formula (I), (I'), (II) or (II’) as defined herein after comprise the conventional non-toxic salts of said compounds, such as those formed from organic or inorganic acid or from organic or inorganic base.
As salts of the compounds of formula (I), (I’), (II) or (II') mention may be made of : the salts obtained by addition of the compound of formula (I) or (II) to : a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example; or an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine. This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and/or oxygen atoms and may thus comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2-(hydroxymethyl)-1,3-propanediol and 3- (dimethylamino)propylamine.
Mention may also be made of the salts of amino acids, for instance lysine, arginine, guanidine, glutamic acid and aspartic acid. Advantageously, the salts of the compounds of formula (I) or (II) (when it comprises a carboxy group) may be chosen from alkali metal or alkaline-earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.
■ as "organic or inorganic acid salt’ is more particularly chosen from salts chosen from a salt derived from i) hydrochloric acid HCI, ii) hydrobromic acid HBr, iii) sulfuric acid -H2SO4 iv) alkylsulfonic acids: Alk-S(O)2OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S(O)2OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-0-S(0)OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysulfinic acid; xii) phosphoric acid H3PO4; xiii) acetic acid CH3C(O)OH; xiv) triflic acid CF3SO3H; and xv) tetrafluoroboric acid HBF4;
■ The acceptable solvates of the compounds described in the instant disclosure comprise conventional solvates such as those formed during the preparation of said compounds owing to the presence of solvents. Mention may be made, by way of example, of the solvates due to the presence of water or of linear or branched alcohols, such as ethanol or isopropanol.
■ The optical isomers are in particular, the enantiomers and the diastereoisomers.
The compounds used according to the instant disclosure therefore correspond to formula (I) or tautomer (I') below or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture.
Figure imgf000016_0001
In which Formulas (I) and (I’) :
R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -0-R3 ii) -S-R3; R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3-C12 or cyclic C3- C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C3 alkoxy radicals R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group;
The compound (I') is the tautomer form of the compound (I) when a tautomeric equilibrium exists according to the following scheme:
Figure imgf000017_0001
According to one embodiment of the disclosure R1 represents one hydrogen atom. According to another embodiment of the disclosure R1 represents a linear (C1-C10)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C3)alkyl group or branched (C3-C3)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. Particularly the said alkyl group of R1 is not substituted.
According to one embodiment of the disclosure R2 represents one hydrogen atom.
According to another embodiment of the disclosure R2 represents a linear (C1-C10)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C3)alkyl group or branched (C3-C6)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group ; the said alkyl group of R2 being not substituted.
According to another embodiment of the disclosure R2 represents a linear (C1-C10)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C6)alkyl group or branched (C3-C6)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i), ii), iii) and iv) as defined herein before. Preferably the said alkyl group being substituted by one or two groups selected from I), ii) and iii), more preferably by one or two groups selected from i) and iii), better substituted by one group iii) as carboxy.
Another variant for radical R2 is that the said alkyl group being substituted by one group iv) especially substituted by one phenyl group.
According to another embodiment of the disclosure R2 represents a (C3-C8)cycloalkyl group, preferably a (C5-C7)cycloalkyl group such cyclohexyl.
According to another embodiment of the disclosure R2 represents C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals, preferably a phenyl group particularly not substituted.
According to an embodiment R3 represents a hydrogen atom.
According to another embodiment R3 represents a saturated linear C1-C10 or branched C3-C10 alkyl group; particularly a linear (C1-C3)alkyl group or a branched (C3-C6)alkyl group, preferably (C1-C4)alkyl group such as methyl group. Preferably, the compounds of formula (I) and tautomer (I') or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
Ri denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C6 or branched C3-C3 alkyl group optionally substituted with one or more groups, which may be Identical or different, chosen from: i) -O-R3 ii) -S-R3; preferably optionally substituted with one or more groups i)
R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C10 or branched C3-C10 or cyclic C3- C8 such as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -SR-3 iii) -C(O)-O-R3 ; iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C1-C4 alkoxy radicals such as methoxy ; preferably substituted with one or more groups selected from I) and iii), preferably iii) such as carboxy R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C3 or branched C3-C3 alkyl group Preferentially, the compounds of formula (I) and tautomer (I') or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR3 . more preferably not substituted; R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C10 or branched C3-C10 or cyclic C3-C8 as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C4 alkoxy radicals; R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group such as methyl or ethyl .
Preferentially, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
R1 is a hydrogen atom; and R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C5 or branched C3-C5 or cyclic C3- C8 as C5 -C6 , substituted with one or more groups, which may be identical or different, chosen from v) -C(O)-O-R3, preferably substituted with one group iii) -C(O)-O-R3 ; R2 is even more preferably a saturated hydrocarbonated group linear C1-C4 or branched C3-C4 substituted with one group iii) -C(O)-OR3 .
According to another preferred embodiment, compounds of formula (I) and tautomer
Figure imgf000021_0001
are selected among compounds of formula (II) and also the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture :
Figure imgf000021_0002
Formula (I) and (I') Wherein R1 and R3 have the same meaning than for compounds of formula (I) and (I') and X denotes an alkylene radical -(CH2)n- with n being an integer ranging inclusively from 1 to 10, preferably ranging from 1 to 6, more preferably ranging from 1 to 4, such as 1, preferably R3 represents a hydrogen atom.
Among the compounds of formula (I), the following compounds are preferably used and their tautomer or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture:
Figure imgf000021_0003
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000024_0001
Figure imgf000025_0001
Figure imgf000026_0001
Among these compounds, the following compounds are more particularly preferred:
Figure imgf000026_0002
Figure imgf000027_0001
Figure imgf000028_0001
Figure imgf000029_0001
More preferably, among these compounds, the following compounds are more particularly preferred:
Figure imgf000029_0002
Figure imgf000030_0001
Figure imgf000031_0001
Even more preferably, among these compounds, the following compounds are more particularly preferred:
Figure imgf000031_0002
Figure imgf000032_0001
In a most preferred embodiment, the compound according to the instant disclosure is the following:
Figure imgf000032_0002
All compounds can be obtained by chemical method known by man skilled in the art, from commercially available reagents. We can for example use the synthetic method disclosed in the European patent application EP3 390 363.
The composition used according to the disclosure comprises at least one compound of formulae (I) and/or (II) as described above, in a physiologically acceptable medium.
The compound (I), (I'), (II) and/or (IP) may be present in the composition used according to the disclosure in an amount which may be between 0.01% and 10% by weight, preferably between 0.1% and 5% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.
Natural Emulsifiers
In various embodiments, the natural emulsifiers may be chosen from: Inulin Lauryl Carbamate, C12-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Cetearyl wheat straw glycosides and Cetearyl alcohol, Sorbitan Olivate, Glyceryl citrate stearate, Cetearyl Olivate (and) Sorbitan Olivate, other sucrose and glucose esters and ethers, amino acid-based emulsifiers, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
Suitable hydrophobically-modifled natural emulsifiers include, for example, inulin lauryl carbamate, commercially available from Beneo Orafti under the tradename Inutec SP1.
Suitable natural emulsifiers with an HLB around about 10 include, but are not limited to, polyglycerides and mixture thereof.
The fatty add esters of a sugar that can be used as non ionic amphiphilic lipids can be chosen in particular from the group comprising esters or mixtures of esters of a C8-C22 fatty acid and of sucrose, of maltose, of glucose or of fructose, and esters or mixtures of esters of a C14-C22 fatty acid and of methylglucose. The C8-C22 or C1 4- C22 fatty acids forming the fatty unit of the esters that can be used in the emulsion comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms. The fatty unit of the esters can be chosen in particular from stearates, behenates, arachidonates, palmitates, myristates, laurates, caprates and mixtures thereof.
By way of example of esters or of mixtures of esters of a fatty acid and of sucrose, of maltose, of glucose or of fructose, mention may be made of sucrose monostearte, sucrose distearate, sucrose tristearate and mixtures thereof, such as the products sold by the company Croda under the name Crodesta F50, F70, F1 10 and F160 having, respectively, an HLB (Hydrophilic Lipophilic Balance) of 5, 7, 1 1 and 16; and, by way of example of esters or of mixtures of esters of a fatty acid and of methylglucose, mention may be made of the disearate of methylglucose and of polyglycerol-3, sold by the company Goldschmidt under the name Tego-care 450. Mention may also be made of glucose monoesters or maltose monoesters, such as methyl O-hexadecanoyl-6-D-glucoside and O-hexadecanoyl-6-D-maltoside.
The fatty alcohol ethers of a sugar that can be used as nonionic amphiphilic lipids can be chosen in particular form the group comprising ethers or mixtures of ethers of a 08-022 fatty alcohol and of glucose, of maltose, of sucrose or of fructose, and ethers or mixtures of ethers of a C 4-C22 fatty alcohol and of methylglucose. They are in particular alkylpolyglucosides.
The C8-C22 or C14-C22 fatty alcohols forming the fatty unit of the ethers that can be used in the emulsion of the instant disclosure comprise a saturated or unsaturated linear alkyl chain having, respectively, from 8 to 22 or from 14 to 22 carbon atoms. The fatty unit of the ethers can be chosen in particular from decyl, cetyl, behenyl, arachidyl, stearyl, palmityl, myristyl, lauryl, capryl and hexadecanoyl units, and mixtures thereof such as cetearyL
By way of example of fatty alcohol ethers of a sugar, mention may be made of alkylpolyglucosides, such as decylglucoside and laurylglucoside sold, for example, by the company Henkel under the respective names Plantaren 2000 and Plantaren 1200, cetostearylglucoside, optionally as a mixture with cetostearyl alcohol, sold, for example, under the name Montanov 68 by the company Seppic, under the name Tego-care CG90 by the company.
Goldschmidt and under the name Emulgade KE3302 by the company Henkel, and also arachidylglucoside, for example in the form of the mixture of arachidyl and behenyl alcohols and of arachidylglucoside sold under the name Montanov 202 by the company Seppic. Use is more particularly made, as nonionic amphiphilic lipid of this type, of sucrose monostearate, sucrose distearate, sucrose tristearate and mixtures thereof, the distearate of methylglucose and of polyglycerol-3, and alkylpolyglucosides.
The natural emulsifiers having an HLB from around about 10 to about 15 will typically be employed in an amount of from about 0.5 to about 8 wt%, based on the total weight of the composition.
The total amount of natural emulsifier present in the compositions is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
Polyglyceryl Fatty Acid Ester
In various embodiments, the natural emulsifiers may be chosen from one or more polyglyceryl fatty acid ester having an HLB value of 8.0 or more, preferably 8.5 or more, and more preferably 9.0 or more. A single type of polyglyceryl fatty acid ester may be used, but two or more different types of first polyglyceryl fatty acid ester may be used in combination.
The one or more polyglyceryl fatty acid ester may have an HLB value of from 8.0 to 20.0, preferably from 8.5 to 18, and more preferably from 9.0 to 14.0.
The term HLB ("hydrophilic-lipophilic balance") is well known to those skilled in the art and reflects the ratio between the hydrophilic part and the lipophilic part in the molecule.
The one or more polyglyceryl fatty acid ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
It is preferable that the one or more polyglyceryl fatty acid ester comprises 2 to 4 glycerol units, preferably 3 or 4 glycerol units, and more preferably 4 glycerol units.
The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 12 or fewer carbon atoms, preferably 11 or fewer carbon atoms, and more preferably 10 or fewer carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 4 or more carbon atoms, preferably 6 or more carbon atoms, and more preferably 8 or more carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have carbon atoms of from 4 to 12, preferably from 6 to 11, and more preferably from 8 to 10 carbon atoms.
The fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from caprylic acid, capric acid, and lauric acid.
The one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), PG5 myristate (HLB: 15.4), PG5 stearate (HLB: 15), PG-5 oleate (HLB 11.5), PG6 caprylate (HLB: 14.6), PG6 caprate (HLB: 13.1), PG6 laurate (HLB: 14.1), PG10 laurate (HLB: 15.2), PG10 myristate (HLB: 14.9), PG10 stearate (HLB: 14.1), PG10 isostearate (HLB: 13.7), PG-10 diisostearate (HLB: 11), PG10 oleate (HLB: 13.0), PG10 cocoate (HLB: 16), and mixtures thereof.
It may be preferable that the one or more polyglyceryl fatty add ester(s) be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), and mixtures thereof.
The one or more polyglyceryl fatty add ester may be chosen from mono, di, tri and more esters of saturated or unsaturated fatty acid(s).
The fatty add for the fatty add moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may comprise 14 or more carbon atoms, preferably 16 or more carbon atoms, and more preferably 18 or more carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty add ester may comprise 30 or fewer carbon atoms, preferably 24 or fewer carbon atoms, and more preferably 20 or fewer carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl fatty acid ester may have from 14 to 30, preferably from 16 to 24, and more preferably from 18 to 20 carbon atoms. The fatty acid for the fatty acid moiety of the one or more polyglyceryl fatty acid ester may be saturated or unsaturated, and may be selected from myristic acid, stearic acid, isostearic acid, and oleic acid.
The one or more polyglyceryl fatty acid ester(s) may be selected from the group consisting of PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), PG6 distearate (HLB: 8), PG10 distearate (HLB: about 9), PG10 tristearate (HLB: 8), PG10 diisostearate (HLB: 10), PG10 triisostearate (HLB: 8), PG10 tricocoate (HLB: 9), and mixtures thereof.
It may be preferable that the one or more polyglyceryl fatty acid be selected from the group consisting of PG2 isostearate (HUB: 8), PG2 oleate (HLB: 8), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopalmitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), and mixtures thereof.
As examples of the one or more polyglyceryl fatty acid ester, mention may be made of Sunsoft® Q-17D(G) from Taiyo Kagaku Co., Ltd., Sunsoft® A-121 E-C from Taiyo Kagaku Co., Ltd., and Tegosoft® PC 41 from Evonik Co., Ltd.
The amount of the one or more polyglyceryl fatty acid ester(s) in the composition according to the Instant disclosure may be from about 0.5 to about 3 wt.% based on the total weight of the cosmetic composition.
The total the one or more polyglyceryl fatty acid esters) in the composition is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8, 3.0 wt.% to about 3.0, 3.2, 3.4, 3.6, 3.8, 4.0, 4.2, 4.4, 4.6, 4.8, 5.0, 5.2, 5.4, 5.6, 5.8, 6.0, 6.2, 6.4, 6.6, 6.8, 7.0, 7.5 or 8.0 wt.%, based on the total weight of the composition.
A log P value is a value for the base-ten logarithm of the apparent octan-1- ol/water partition coefficient. The log p values are known and are determined by a standard test which determines the concentration of the (c) compound in octan-1-ol and water. The log P may be calculated according to the method described in the article by Meylan and Howard: Atom/Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84: 83-92, 1995. This value may also be calculated using numerous commercially available software packages, which determine the log P as a function of the structure of a molecule. By way of example, mention may be made of the Epiwin software from the United States Environmental Agency.
The values may especially be calculated using the ACD (Advanced Chemistry Development) Solaris software V4.67; they may also be obtained from Exploring QSAR: hydrophobic, electronic and steric constants (ACS professional reference book, 1995). There is also an Internet site which provides estimated values (address: http://esc.syrres.com/interkow/kowdemo.htm).
The composition may also include Vitamin B3 and derivatives.
Vitamin B3, also called vitamin PR, is a compound of the following formula:
Figure imgf000038_0001
in which R may be -CONH2 (niacinamide), -COOK (nicotinic acid or niacin), or CH2OH (nicotinyl alcohol), -CO-NH-CH2-COOH (nicotinuric acid) or -CO-NH-OH (niconityl).
Oil(s)
The cosmetic compositions include an oil phase comprising one or more oils. The amount of oil phase (e.g., the total amount of oils) is typically in 0.5 to 40 wt.%, based on the total weight of the cosmetic composition. In some instances, the cosmetic composition includes oils that are plant based or vegetable based oils.
The amount of oils present in the cosmetic composition may be from about 0.5 to about 40 wt%, about 0.5 to about 38 wt%, about 0.5 to about 34 wt.%, about 0.5 to about 32 wt.%; 0.5 to about 30 wt.%, 0.5 to about 28 wt.%, 0.5 to about 26 wt.%, 0.5 to about 24 wt.%, about 1 to about 40 wt.%, 1 to about 38 wt.%, 1 to about 36 wt.%, 1 to about 34 wt.%, 1 to about 32 wt.%, 1 to about 30 wt.%, 1 to about 28 wt.%, 1 to about 26 wt.%, 1 to about 24 wt.%, about 2 to about 40 wt.%, 2 to about 38 wt.%, 2 to about 36 wt.%, 2 to about 34 wt%, 2 to about 32 wt.%, 2 to about 30 wt.%, 2 to about 28 wt%, 2 to about 26 wt.%, 2 to about 24 wt.%, about 3 to about 40 wt.%, about 3 to about 38 wt.%, about 3 to about 36 wt.%, about 3 to about 34 wt.%, about 3 to about 32 wt%, about 3 to about 30 wt.%, about 3 to about 28 wt.%, about 3 to about 26 wt.%, about 3 to about 24 wt.%, about 4 to about 40 wt.%, about 3 to about 38 wt.%, about 4 to about 36 wt.%, about 4 to about 34 wt.%, about 4 to about 32 wt.%, about 4 to about 30 wt.%, about 4 to about 28 wt.%, about 4 to about 26 wt.%, about 5 to about 40 wt.%, about 5 to about 38 wt.%, about 5 to about 36 wt.%, about 5 to about 34 wt%, about 5 to about 32 wt.%, about 5 to about 32 wt.%, about 5 to about 30 wt%, about 5 to about 28 wt.%, about 5 to about 26 wt.%, or about 5 to about 24 wt.%, including all ranges and sub-ranges therebetween, based on the total weight of the cosmetic composition.
Additionally and/or alternatively, the cosmetic composition may exclude synthetic oils. In some case, the cosmetic composition may exclude oils other than plant based and vegetable based oils. For example, the amount of synthetic oils and/or oils other than plant based and vegetable based oil may be about 5 wt.% or less, about 4 wt.% or less, about 3 wt.% or less, about 2 wt.% or less, about 1 wt.% or less, or about 0.5 wt.% or less, based on the total weight of the cosmetic composition. In at least one embodiment, the cosmetic composition is free of or essentially free of synthetic oils and/or oils other than plant based and vegetable based oil.
The term "oil" means any fatty substance which is in liquid form at room temperature (20-25°C.) and at atmospheric pressure (760 mmHg). Often, at least one of the oils in the cosmetic composition is part of an oily phase. An "oily phase" is a phase comprising at least one oil that may include additional liposoluble and lipophilic ingredients and the fatty substances. Oil that is suitable for use herein may be volatile or non-volatile. The term "volatile oil" relates to an oil that is capable of evaporating on contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure. Volatile oil(s) are liquid at room temperature and have a nonzero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40 000 Pa (10-3 to 300 mmHg). The term "non-volatile oil" relates to an oil that remains on the skin or the keratin fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10-3 mmHg (0.13 Pa). pH Adjusting Agent
The composition according to the present invention may comprise at least one pH adjusting agent (pH adjuster). Two or more pH adjusting agents may be used in combination. Thus, a single type of pH adjusting agent or a combination of different types of pH adjusting agents may be used.
As the pH adjusting agent, at least one acidifying agent and/or at least one basifying agent (alkaline agent) may be used.
The acidifying agent may be a monovalent or polyvalent, such as divalent, acid.
The acidifying agents can be, for example, mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid, or organic acids such as carboxylic acids, for instance tartaric acid, citric acid, and lactic acid, as well as sulphonic acids.
The basifying agent may be a monovalent or polyvalent, such as divalent, base.
The basifying agents may be mineral (inorganic) or organic, or hybrid.
The mineral basifying agents may be chosen from aqueous ammonia; alkali metal carbonates or bicarbonates such as sodium or potassium carbonates and sodium or potassium bicarbonates; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; and mixtures thereof.
The organic basifying agents may be chosen from organic amines with a pKb at 25°C of less than 12, preferably less than 10, and even more advantageously less than 6. It should be noted that it is the pKb corresponding to the function of highest basicity. In addition, the organic amines do not comprise any alkyl or alkenyl fatty chains comprising more than ten carbon atoms. The organic basifying agent may be chosen, for example, from akanolamines, oxyethylenated and/or oxypropylenated ethylenediamines, amino acids and amine compounds of formula (III) below:
Figure imgf000041_0001
in which
W represents a C1-C6 divalent alkylene radical optionally substituted with one or more hydroxyl groups or a C1-C8 alkyl radical, and optionally interrupted with one or more heteroatoms such as O and N, and
Rx, Ry, Rz, and Rt, which may be identical or different, represent a hydrogen atom or a C1-C3 alkyl, C1-C3 hydroxyalkyl, or C1-C3 aminoalkyl radical.
Examples of the amine compounds of formula (III) that may be mentioned include 1,3- diaminopropane, 1 ,3-diamino-2-propanol, spermine and spermidine.
The term “alkanolamine" means an organic amine comprising a primary, secondary or tertiary amine function, and one or more linear or branched C1-C8 alkyl groups bearing one or more hydroxyl radicals.
Alkanolamines such as monoalkanolamines, dialkanolamines or trialkanolamines comprising one to three identical or different C1-C4 hydroxyalkyl radicals may be suitable for the present invention. Among the compounds of this type, mention may be made of monoethanolamine (MEA), diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylaminoethanolamine, 2-amino- 2-methyl-1 -propanol, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 3-amino- 1 ,2-propanediol, 3-dimethylamino-1,2-propanediol and tris(hydroxymethylamino)methane.
Amino acids that may be used are of natural or synthetic origin, in their L, D or racemic form, and comprise at least one acid function chosen more particularly from carboxylic acid, sulfonic acid, phosphonic acid or phosphoric acid functions. The amino acids may be in neutral or ionic form.
As amino acids that may be used in the present invention, mention may be made especially of aspartic acid, glutamic acid, alanine, arginine, ornithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleuclne, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine and valine.
It may be preferable that the amino acids are basic amino acids comprising an additional amine function optionally included in a ring or in an ureido function.
Such basic amino acids may preferably be chosen from those corresponding to formula (IV) below:
Figure imgf000042_0002
in which
R represents a group chosen from:
Figure imgf000042_0001
-(CH2)3-NH2,
-(CH2)2-NH2,
-(CH2)2-NH-CO-NH2, and
Figure imgf000043_0001
The compounds corresponding to formula (IV) include histidine, lysine, arginine, ornithine and citrulline.
The organic basifying agent may be chosen from organic amines of heterocyclic type. Besides histidine that has already been mentioned in the amino adds, mention may in particular be made of pyridine, piperidine, imidazole, triazole, tetrazole and benzimidazole.
The organic basifying agent may also be chosen from amino acid dipeptides. As amino acid dipeptides that may be used in the present invention, mention may be made especially of camosine, anserine and baleine.
The organic basifying agent may also be chosen from compounds comprising a guanidine function. As amines of this type that may be used in the present invention, besides arginine, which has already been mentioned as an amino acid, mention may be made especially of creatine, creatinine, 1,1-dimethylguanidine, 1,1-diethyl-guanidine, glycocyamine, metformin, agmatine, N-amidinoalanine, 3-guanidino-propionic acid, 4- guanidinobutyric acid and 2-([amino(imino)methyl]amino)ethane-1 -sulfonic acid.
In a preferred embodiment of the present invention, the organic basifying agent may be selected from amino acids, preferably basic amino acids, and more preferably arginine, lysine, histidine or mixtures thereof. Even more preferentially, the organic basifying agent may be arginine.
Hybrid compounds that may be mentioned include the salts of the amines mentioned previously with acids such as carbonic acid or hydrochloric acid. Guanidine carbonate or monoethanolamine hydrochloride may be used in particular. The pH adjusting agent may be present in an amount of 0.01 % by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, relative to the total weight of the composition.
The pH adjusting agent may be present in an amount of 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, relative to the total weight of the composition.
The pH adjusting agent may be present in an amount ranging from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight, and more preferably from 0.1% to 5% by weight or less, relative to the total weight of the composition.
It is preferable that the composition according to the present invention have a pH of 4.5 or more, and more preferably 5 or more.
It is preferable that the composition according to the present invention have a pH of 6.5 or less, and more preferably 6 or less.
It is preferable that the composition according to the present invention have a pH of from 4.5 to 6.5, and more preferably from 5 to 6.
The pH of the composition means the pH of the aqueous phase of the composition according to the present invention.
It may be preferable that at least one buffer or buffering agent also be used, as the pH adjusting agent, in combination with the acidifying agent and/or the basifying agent, in order to stabilize the pH of the composition according to the present invention.
As the buffer, any of commonly known buffers may be used. For example, salts of acids or bases, preferably salts of weak acids or weak bases, may be used. For example, sodium citrate or sodium lactate may be used as the buffer, if citric acid or lactic acid is used as the acidifying agent.
Cosmetically Acceptable Carrier System
The cosmetic compositions include a cosmetically acceptable carrier system.
The term "cosmetically acceptable" means a earner that is compatible with any keratinous substrate, and for purposes hereof, includes water and optionally water based solvents subject to any exclusions as disclosed herein.
The cosmetic compositions may comprise any constituent normally employed in the topical application and administration envisaged. Mention may in particular be made of water, solvents, fatty compounds (i.e. described by the International Federation Societies of Cosmetic Chemists, for example, in Cosmetic Raw Material Analysis and Quality, Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994), which is incorporated herein by reference in its entirety), polyols, pigments, fillers, silicones, surfactants, thickeners, gelling agents, preservatives and their mixtures in all proportions.
In some embodiments, the composition may be in the form of macroemulsion.
Macroemulsions are dispersed liquid-liquid, thermodynamically unstable systems with particle sizes ranging from 1 to 100 pm (orders of magnitude), which, most often, do not form spontaneously. Macroemulsions scatter light effectively and therefore appear milky, because their droplets are greater than a wavelength of light.[1] They are part of a larger family of emulsions along with miniemulsions (or nanoemulsions). As with all emulsions, one phase serves as the dispersing agent. It is often called the continuous or outer phase. The remaining phase(s) are disperse or inner phase(s), because the liquid droplets are finely distributed amongst the larger continuous phase droplets.[2j This type of emulsion is thermodynamically unstable, but can be stabilized for a period of time with applications of kinetic energy.[1] Surfactants (as the main emulsifiers) are used to reduce the interfacial tension between the two phases, and induce macroemulsion stability for a useful amount of time. Emulsions can be stabilized otherwise with polymers, solid particles (Pickering emulsions) or proteins.
The macroemulsion may have a dispersed phase with a particle size of no less than 600 nm total as minimum of range. Most likely in micron range, such as 0.8 to 20 microns. They do not form spontaneously (like microemulsions do).
The OA/V architecture or structure, which consists of oil phases dispersed in an aqueous phase, has an external aqueous phase, and therefore if the composition according to the Instant disclosure has the O/W architecture or structure, it can provide a pleasant feeling during use because of the feeling of immediate freshness that the aqueous phase can provide.
The particle size can be measured by a dynamic light scattering method. The particle size measurement can be performed by, for example, the Particle Size Analyzer ELSZ-2000 series, marketed by Otsuka Electronics Co., Ltd.
The particle size can be a volume-average particle diameter or a numberaverage particle diameter, preferably a volume-average particle diameter.
Methods of use
The instant disclosure also relates to methods of using the cosmetic compositions described herein. For example, the cosmetic compositions can be used in a method that comprises applying the cosmetic compositions to the skin of humans. In some cases, the composition is applied to the face. Furthermore, the cosmetic composition can be used in methods for depigmenting and/or bleaching keratin materials, preferably skin, comprising the step of: applying to the keratin substance the composition according to the compositions described herein. The aforementioned methods are non-therapeutic.
The instant disclosure also relates to non-therapeutic cosmetic process for depigmenting, lightening and/or bleaching keratin materials, preferably skin, comprising the step of applying to the keratin substance the composition according to the compositions described herein.
The cosmetic composition may be applied once per day, twice per day, or more than once or twice per day. In some cases, the composition is applied in the evenings before bed. In other cases, the compositions are applied in the morning. In still other cases, the composition may be applied immediately after washing the skin. The compositions may be used once, or for a series of days, weeks, or months. For example, the compositions may be used daily for a period of 1 , 2, 3, 4, 5, 6, 7, 8 or more weeks, or months.
Another aspect of the instant disclosure relates to a use of: a. One or more Polyglyceryl Fatty Acid Ester; for enhancing or improving the skin penetration of b. Compound of thlopyridinone type; in a composition in the form of a macroemulsion comprising: c. One or more oils.
EXAMPLES
Implementation of the present disclosure is provided by way of the following examples. The following examples serve to elucidate aspects of the technology without being limiting in nature.
Example 1
Example 1: Synthesis of compound 20
Compound 20 is synthesized as disclosed in example 2 of patent EP3390363.
Example 2 (Inventive Compositions)
The inventive compositions were prepared using the following general procedure:
Generally, the water soluble raw materials (minus actives) were added to the main kettle and dissolved. Polymers were then added and mixed until well-dispersed. Batch was heated to 75C. In a side kettle, the fatty compounds, silicones, and emulsifiers/surfactants were mixed together and heated to 75C. The side kettle was added to the main kettle while homogenizing well. When well emulsified, the batch was cooled to room temperature, and actives and fillers were added.
Table 1: Inventive Compositions
Figure imgf000047_0001
Figure imgf000048_0001
Table 2: Comparative Compositions
Figure imgf000048_0002
Figure imgf000049_0001
Example 3
Inventive Examples and Comparative Examples were tested for stability. The stability of the inventive and comparative Examples was assessed by following the procedure described below.
24 hours after processing, formulas were visually and sensorially assessed for homogeneity (e.g., no visible separation of phases, syneresis, texture was homogenous as opposed to contain solid parts.) Then, samples were placed in glass jars and placed in temperature controlled chambers at 25°C and 45°C. After 2 weeks, samples were again checked for the aforementioned homogeneity. Acceptable results meant initial stability was acceptable. Acceptable samples were kept in chamber for further analysis over time.
The results are shown in Table 3 below. Table 3: Stability Results with Inventive and Comparative Composition
Figure imgf000050_0001
1 = means the emulsion is stable and homogenous during and soon after processing, and is also stable after at least 2 months at 25’C and 45°C. 2= could be anything from product being not homogenous in texture to after formulation to noticeable separation of phases after 2 weeks at 25°C and/or 45°C
The results demonstrated that it is possible to formulate stable, direct emulsions containing THP, using natural emulsifiers, rather than PEG-containing emulsifiers, which are mainly synthetic emulsifiers. Indeed, THP could be included into a physically stable high viscosity emulsion containing more than 15% of fatty acids. However, having a slightly lower viscosity emulsion would allow for many more architectures with vastly different sensorial attrfoutes. Thinner creams, lotions, and serums containing THP could be developed with natural emulsifiers, while remaining stable and sensorial.
Example 4
The following compositions were prepared using the general procedure described above.
Table 4: Inventive Compositions
Figure imgf000051_0001
Figure imgf000052_0001
Table 5: Comparative Compositions
Figure imgf000052_0002
Example 5
Inventive Examples and Comparative Examples were tested to measure the enhanced penetration of the active ingredients. The enhanced penetration of the inventive and comparative Examples was assessed by following the procedure described below.
The penetration test experiments were performed in a Franz diffusion cell (Hanson) with a Strat-M membrane (Millipore, diameter of 15 mm). This equipment was composed of a donor part and a receptor part with the Strat-M membrane between the donor and receptor parts. The receptor part with a predetermined volume was filled with a receiving solution (0.25 wt.% Tween 80/deionized water) maintained at a temperature of 32 °C, which was continuously stirred with a small magnetic bar. Each of the compositions according to Examples 3-5 and Comparative Examples 3-6 was spread with a spatula on the membrane of the donor part with an amount of 30 mg/cm2. After 5 hours, 200 pl of the receiving solution was withdrawn from the receptor part, while providing the same amount of a new receiving solution to the receptor part to maintain the same penetration conditions. The withdrawn receiving solution was analyzed by HPLC to determine the amount of the active ingredient in the receiving solution. The percentage of the active ingredient that passed through the membrane was calculated by dividing the detected amount of the active ingredient in the receiving solution by the amount of the active ingredient spread on the membrane. The amount of active in the cell was then plotted over time to determine the speed of diffusion through the membrane, as well as the total amount diffused after 24 hrs.
The goal of the study was to show that Polyglyceryl Fatty Acid Ester were able to enhance the penetration of the active ingredients in a traditional oil-in-water macroemulsion.
Several penetration enhancers were studied (i.e. Ethoxydiglycol, Dimethyl isosorbide, Sodium dilauramidoglutamide lysine as well as other raw materials that are not knowns to be penetration enhancers (i.e. Laureth-4 and polyglyceryl-4 caprate).
The results are shown in Figure 1, 2, 3, and 4.
Figure 1 and Figure 2 represented the percentage of the penetration of the thiopyridinone compound (i.e. THP) through the membrane over time.
The Base Formula started to penetrate through the membrane within the hour and kept increasing overtime up to a plateau after 24 hours. The base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
Comp. Ex. 3 and Comp. Ex. 4. showed that the penetration of the THP was slow as well at the beginning. In the case of Comp. Ex. 4, it was even observed that the penetration of the thiopyridinone compound was very limited over time. In the case of Comp. Ex. 3, the penetration increased slowly and reached a plateau as well, but still the penetration didn't reach the high level reached with the base formula. Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4. The penetration of the thiopyridinone compound was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau. Both Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
However, the Inventive Ex. 3 demonstrated that the penetration of the thiopyridinone compound was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours. The inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
These experiments surprisingly demonstrated that the use of at least one Polyglyceryl Fatty Acid Ester influence how fast the penetration of an active occurred through the membrane but simultaneously increased the % of penetration through the membrane.
Figure 3 and Figure 4 represented the percentage of the penetration of Niacinamide through the membrane overtime.
The Base Formula started to penetrate through the membrane within the hour and kept increasing over time up to a plateau after 24 hours. The base formula did not contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
Comp. Ex. 3 and Comp. Ex.4. showed that the penetration of Niacinamide was slow as well at the beginning. In the case of Comp. Ex. 4, it was even observed that the penetration of the THP was very limited over time. In the case of Comp. Ex. 3, the penetration increased slowly and reached a plateau as well, but still the penetration didn't reach the high level reached with the base formula. All Comparative Example didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
Comp. Ex. 6 showed a similar pattern as Comp. Ex. 4. The penetration of the niacinamide was slow and very limited. In the case of Comp. Ex. 5, the penetration was higher at the beginning, then reached a plateau. All Comparative Examples didn't contain any Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20.
However, the Inventive Ex. 4 demonstrated that the penetration of niacinamide was at about 78% at the beginning which was much higher than any of the Comp. Ex. Then, the penetration kept increasing and was above 80% after only few hours. The level of penetration was stable over 24 hours. The inventive example proved that the presence of a Polyglyceryl Fatty Acid Ester with a HLB from about 8 to about 20 not only increased the level of penetration of the active, but surprisingly, make it happened almost immediately after application of the products on the membrane.
These experiments surprisingly demonstrated that the use of at least one Polyglyceryl Fatty Acid Ester influence how fast the penetration of an active occurred through the membrane and simultaneously increased the % of penetration through the membrane and potentially through the human skin.
The comparison of Inventive Ex. and comparative Ex. 3, 4, 5, 6 as well as the Base Formula surprisingly demonstrated that the use of at least one Polyglyceryl Fatty Acid Ester enhanced the penetration of THP as compared to when the Polyglyceryl Fatty Acid Ester is not present, even though the comparative Examples contained known penetration enhancers, such as Ethoxydiglycol, Dimethyl isosorblde, Sodium dilauramidoglutamide lysine. The penetration is better than with the known penetration enhancers.
While the disclosure has been described with reference to described embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the essential scope thereof. Therefore, it is intended that the disclosure not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this disclosure, but that the disclosure will include all embodiments falling within the scope of the appended claims.
The term “INCI” is an abbreviation of International Nomenclature of Cosmetic Ingredients, which is a system of names provided by the International Nomenclature Committee of the Personal Care Products Council to describe personal care ingredients.
The articles “a" and "an," as used herein, mean one or more when applied to any feature in embodiments of the present disclosure described in the specification and claims. The use of “a" and “an" does not limit the meaning to a single feature unless such a limit is specifically stated. The article “the" preceding singular or plural nouns or noun phrases denotes a particular specified feature or particular specified features and may have a singular or plural connotation depending upon the context in which it is.
‘At least one," as used herein, means one or more and thus includes individual components as well as mixtures/combinations.
The transitional terms “comprising", "consisting essentially of and "consisting of, when used in the appended claims, in original and amended form, define the claim scope with respect to what unrecited additional claim elements or steps, if any, are excluded from the scope of the claim(s). The term “comprising” is intended to be inclusive or open-ended and does not exclude any additional, unrecited element, method, step or material. The term “consisting of excludes any element, step or material other than those specified in the claim and, in the latter instance, impurities ordinarily associated with the specified material(s). The term "consisting essentially of limits the scope of a claim to the specified elements, steps or material(s) and those that do not materially affect the basic and novel characteristic(s) of the claimed disclosure. All materials and methods described herein that embody the present disclosure can, in alternate embodiments, be more specifically defined by any of the transitional terms “comprising," “consisting essentially of," and “consisting of."
The terms "free" and “devoid" indicates that no reliably measurable excluded material is present in the composition, typically 0% by weight, based on the total weight of the composition. The term "essentially free" means that, while it prefers that no excluded material is present in the composition, it is possible to have very small amounts of the excluded material in the composition of the disclosure, provided that these amounts do not materially affect the advantageous properties of the canposition. In particular, “essentially free” means that excluded material can be present in the composition at an amount of less than about 0.1% by weight, based on the total weight of the composition.
Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and/or reaction conditions are to be understood as being modified In all instances by the term “about," meaning within 10% of the indicated number (e.g. "about 10%" means 9% - 11% and “about 2%" means 1.8% - 2.2%).
All percentages and ratios are calculated by weight unless otherwise indicated.
All percentages are calculated based on the total composition unless otherwise indicated. Generally, unless otherwise expressly stated herein, “weight" or "amount" as used herein with respect to the percent amount of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material.
The terms “weight percent" and “wt%" may be used interchangeably and mean percent by weight, based on the total weight of a composition, article or material, except as may be specified with respect to, for example, a phase, or a system that is a component of a composition, article or material. All ranges and amounts given herein are intended to include subranges and amounts using any disclosed point as an end point. Thus, a range of "1% to 10%, such as 2% to 8%, such as 3% to 5%,” is intended to encompass ranges of "1% to 8%," "1% to 5%," "2% to 10%," and so on. All numbers, amounts, ranges, etc., are intended to be modified by the term “about," whether or not so expressly stated. Similarly, a range given of “about 1% to 10%" is intended to have the term “about" modifying both the 1% and the 10% endpoints. Further, it is understood that when an amount of a component is given, it is intended to signify the amount of the active material unless otherwise specifically stated.
Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the disclosure are approximations, unless otherwise indicated the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. The example that follows serves to illustrate embodiments of the present disclosure without, however, being limiting in nature.
All publications and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. In the event of an inconsistency between the present disclosure and any publications or patent application incorporated herein by reference, the present disclosure controls.

Claims

1. An oil-in-water cosmetic composition comprising: i) at least one compound selected from compounds of formula (I) and tautomer of formula (I') below or their salts; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
Figure imgf000059_0001
In which Formulas (I) and (I') :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 :
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3- C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals
- R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; ii) at least two or more natural emulsifiers; and wherein the oil-in-water cosmetic composition is physically stable.
2. The composition according to claim 1 in which radical : R1 of formula (I) and (I') represents a hydrogen atom, or
- R1 of formula (I) and (I') represents a linear (C1-C10)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C3)alkyl group or branched (C3- C3)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl, particularly the said alkyl group of R1 is not substituted.
3. The composition according to any one of the preceding claims in which : R2 of formula (I) and (I') represents a hydrogen atom; or
- R2 of formula (I) and (I') represents a linear (C1-Cw)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C3)alkyl group or branched (C3- C3)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl group ; the said alkyl group of R2 being not substituted.
4. The composition according to claim 1 or 2 in which radical :
- R2 of formula (I) and (I') represents a linear (C1-C10)alkyl group or branched (C3-C10)alkyl group, especially a linear (C1-C6)alkyl group or branched (C3- C3)alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; the said alkyl group being substituted by one or more groups selected from i), ii), iii) and iv) as defined in claim 1, preferably the said alkyl group being substituted by one or two groups selected from i), ii) and iii), more preferably by one or two groups selected from i) and iii), better substituted by one group iii) as carboxy.
5. The composition according to claim 1 or 2 in which radical : R3 of formula (I) and (I’) represents a (C3-C8)cycloalkyl group, preferably a (C5-C7)cycloalkyl group such cyclohexyl; or
Rs of formula (I) and (I') represents a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals, preferably a phenyl group particularly not substituted.
6. The composition according to any one of the preceding claims in which : R3 of formula (I) and (I') represents a hydrogen atom; or R3 of formula (I) and (I') represents a saturated linear C1-C10 or branched C3- C10 alkyl group; particularly a linear (C1-C6)alkyl group or a branched (C3- C3)alkyl group, preferably (C1-C4)alkyl group such as methyl group.
7. The composition according to any one of the preceding claims in which : R1 of formula (I) and (I') represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C3 or branched C3-C6 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3; preferably optionally substituted with one or more groups i) R2 of formula (I) and (I') represents a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C10 or branched C3-C10 or cyclic C3-C8 such as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -SR-3 iii) -C(O)-O-R3 ; iv) a phenyl group optionally substituted with one or more hydroxyls and/or with one or more C1-C4 alkoxy radicals such as methoxy ; preferably substituted with one or more groups selected from i) and iii), preferably iii) such as carboxy R3 of formula (I) and (I') represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C6 or branched C3-C6 alkyl group; preferentially, the compounds of formula (I) and tautomer (I’) or their salts, their optical isomers, racemates, and/or solvates such as hydrates and the thereof, alone or as a mixture; have the following meanings:
R1 of formula (I) and (I’) represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from i) -OR3 , more preferably not substituted; R2 of formula (I) and (I') represents a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C10 or branched C3-C10 or cyclic C3-C8 as C5 -C6 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C4 alkoxy radicals; R3 of formula (I) and (I') represents a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C4 or branched C3-C4 alkyl group such as methyl or ethyl .
8. The composition according to any one of the preceding claims in which compounds of formula (I), the compounds 1 to 24 and their tautomer or their salts, their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture, particularly compounds 1, 2, 4, 6, 7, 9, 11, 12, 14, 15, 16, 17, 18, 19, 20, or 21, more particularly 1, 9, 16, 18, 19, 20, or 21, preferably 18, 19, 20, or 21, more preferably 20 :
Figure imgf000063_0001
Figure imgf000064_0001
Figure imgf000065_0001
Figure imgf000066_0001
Figure imgf000067_0001
9. The composition according to any one of the preceding claims in which the compound il) represents at least two or more natural emulsifiers.
10. The composition according to any one of the preceding claims, wherein the compound i) is present from about 0.01 to about 10 wt.%, based on the total weight of the cosmetic composition.
11.The composition according to any one of the preceding claims, wherein the at least two or more natural emulsifiers ii) is a blend of natural emulsifiers having a HLB from about 10 to about 15.
12. The composition according to any one of the preceding claims, wherein the at least two or more natural emulsifiers ii) is selected from the group consisting of inulin lauryl carbamate, C12-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof.
13.The composition according to any one of the preceding claims, wherein the at least two or more natural emulsifiers ii) is present from about 0.5 to about 6 wt.%, based on the total weight of the cosmetic composition.
14. The composition according to any one of the preceding claims, wherein the pH is from about 4.5 to about 6.5.
15. An oil-in-water cosmetic composition comprising: i) from about 0.01 to about 10 wt.% of at least one compound selected from compounds of formula (I) and tautomer of formula (I’) herein below or their salts; and their optical isomers, racemates, and/or solvates such as hydrates, alone or as a mixture :
Figure imgf000069_0001
In which Formulas (I) and (I') :
- R1 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 ;
- R2 denotes a radical chosen from: a) a hydrogen atom; b) a saturated hydrocarbonated group linear C1-C12 or branched C3- C12 or cyclic C3-C8 , optionally substituted with one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals; c) a C5-C12 aryl group optionally substituted with one or more hydroxyls and/or with one or more C1-C8 alkoxy radicals
- R3 denotes a radical chosen from: a) a hydrogen atom; b) a saturated linear C1-C10 or branched C3-C10 alkyl group; ii. about 0.5 to about 2 wt.% of at least two or more natural emulsifiers that are elected from the group consisting of inulin lauryl carbamate, C1 2-20 Alkyl Glucoside, Cetearyl Alcohol (and) Cetearyl Glucoside, APGs, Arachidyl Alcohol (And) Behenyl Alcohol (And) Arachidyl Glucoside, Polyglyceryl-3 Methylglucose Distearate, Glyceryl citrate stearate, sucrose and glucose esters and ethers, amino acid-based emulsifier, Hydrogenated lecithin, lecithins, Sodium lauroyl glutamate, sodium stearoyl glutamate and a mixture thereof. wherein the weight percentages are based on the total weight of the cosmetic composition.
16. A method for treating skin comprising applying the cosmetic composition of claim 1 to the skin.
17A non-therapeutic cosmetic process for depigmenting, lightening and/or bleaching keratin materials, preferably skin, comprising the step of applying to the keratin substance the composition according to any one of Claims 1 to 15.
PCT/US2023/025681 2022-06-21 2023-06-19 Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds WO2023249915A1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US17/844,930 US20230404883A1 (en) 2022-06-21 2022-06-21 Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds
US17/844,930 2022-06-21
US17/844,949 2022-06-21
US17/844,949 US20230404882A1 (en) 2022-06-21 2022-06-21 Composition comprising compound of thiopyridinone type and polyglyceryl-based emulsifiers
FR2211483A FR3141622A1 (en) 2022-11-04 2022-11-04 COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS
FR2211482 2022-11-04
FR2211483 2022-11-04
FR2211482A FR3141624A1 (en) 2022-11-04 2022-11-04 COMPOSITION COMPRISING A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS

Publications (1)

Publication Number Publication Date
WO2023249915A1 true WO2023249915A1 (en) 2023-12-28

Family

ID=87158418

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/025681 WO2023249915A1 (en) 2022-06-21 2023-06-19 Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds

Country Status (1)

Country Link
WO (1) WO2023249915A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106074663A (en) * 2016-08-24 2016-11-09 广州睿森生物科技有限公司 One Plant Extracts and steroid-dependent dermatitis repair cream
EP3390363A1 (en) 2015-12-18 2018-10-24 L'oreal Process for depigmenting keratin materials using thiopyridinone compounds
US20210401715A1 (en) * 2020-06-30 2021-12-30 L'oreal Cosmetic composition for improved penetration
WO2022079122A1 (en) * 2020-10-15 2022-04-21 L'oreal Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3390363A1 (en) 2015-12-18 2018-10-24 L'oreal Process for depigmenting keratin materials using thiopyridinone compounds
CN106074663A (en) * 2016-08-24 2016-11-09 广州睿森生物科技有限公司 One Plant Extracts and steroid-dependent dermatitis repair cream
US20210401715A1 (en) * 2020-06-30 2021-12-30 L'oreal Cosmetic composition for improved penetration
WO2022079122A1 (en) * 2020-10-15 2022-04-21 L'oreal Use of thiopyridinone compounds for preventing the formation of cutaneous blackheads

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Particle Size Analyzer ELSZ-2000", OTSUKA ELECTRONICS CO., LTD
J. PHARM. SCI., vol. 84, 1995, pages 83 - 92

Similar Documents

Publication Publication Date Title
JP6016728B2 (en) Ceramide dispersion composition
JP5453715B2 (en) Hair nurturing agent and transdermal absorption enhancer
KR100873664B1 (en) Hair restorer
JP2015178437A (en) Coated titanium dioxide to reduce whitening effect on skin
JP2015533170A (en) Cosmetic composition comprising at least one hydrotrope and at least one active compound
JP2007022997A (en) Emulsified composition
JPH07316023A (en) Hair tonic
KR20040071183A (en) Ceramide emulsions
WO2023249915A1 (en) Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds
MXPA04001137A (en) Topical composition for follicular delivery of an ornithine decarboxylase inhibitor.
JP2006290751A (en) Oil-in-water type emulsion and method for producing the same
JPWO2020067132A1 (en) Topical composition containing ascorbic acid and / or a salt thereof
US20230404882A1 (en) Composition comprising compound of thiopyridinone type and polyglyceryl-based emulsifiers
JP2022526141A (en) Plant peptides and their uses (II)
JP6702783B2 (en) Skin penetration enhancer
JP7479898B2 (en) Transdermal absorption inhibitors
US20140128615A1 (en) Preservation Of Ergothioneine
US20230404883A1 (en) Cosmetic composition comprising natural emulsifiers and thiopyridinone compounds
JP7328957B2 (en) External composition containing ascorbic acid and/or its salt
FR3141622A1 (en) COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS
WO2020126732A1 (en) Composition comprising a monoglyceride, a tartaric ester of monoglyceride and a salicylic acid compound
FR3141624A1 (en) COMPOSITION COMPRISING A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS
WO2023245461A1 (en) Composition for delivery of active compound
US20230404884A1 (en) Cosmetic composition comprising hydrophilic antioxidants and thiopyridinone compounds
WO2023249912A1 (en) Cosmetic composition comprising hydrophilic antioxidants and thiopyridinone compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23739023

Country of ref document: EP

Kind code of ref document: A1